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Overview
This volume of the thesis comprises the major research project, and it is presented in 
three parts. The first part consists of the review paper, which is a focused review of the 
literature on outcome in psychological therapies for persistent pain. The second part is 
the empirical paper. The empirical paper will report on my study, which examines the 
extent to which cognitive and behavioural adherence predicts better outcome of 
cognitive-behavioural therapy for persistent pain. The final part of the thesis is formed 
of the critical appraisal. This section provides the opportunity to critically reflect on the 
whole process of conducting this piece of research.
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Abstract
Background: The varied effectiveness of Cognitive-Behavioural Therapy (CBT) and 
other psychological therapies in the treatment of persistent pain has led researchers to 
examine a range of factors that may predict treatment response. Studies have identified 
a diverse set of personal (i.e., age, gender, and marital status), specific (i.e., level of 
depression, treatment expectancy, and catastrophising), and non-specific (i.e., adherence 
to treatment) variables that appear to be associated with treatment outcome, although 
few with any consistency. This review summarises the available literature on predictors 
of outcome for persistent pain and discusses limitations of such studies.
Data Sources and Review Method: The persistent pain literature was examined to
identify proposed variables that predict response to multicomponent treatment for 
persistent pain. PsycINFO and Medline databases were searched spanning articles 
published from 1990 to 2006 of treatment studies and review articles.
Results: Very few studies that focused on predictors of outcome following CBT for 
persistent pain in the adult population were found through the database searches. 
Therefore, in addition, a hand-search of key journals, of reference lists from searched 
articles, and of relevant books was completed and articles prior to 1990 were 
consequently included in the review at the author’s discretion. All types of persistent 
pain were included except headache.
Conclusions: Main results: The review showed that of the many personal variables 
investigated to influence outcome, only socioeconomic status (SES), social support, and 
applying for compensation or disability pension consistently predicted outcome. Of the
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specific variables, changes in catastrophising, self-efficacy, pain-related fear, pain 
tolerance, pain helplessness and perceived disability have each been shown to 
consistently predict outcome. Few studies were found that had investigated the role of 
adherence during or after treatment on treatment outcome. Finally, suggestions for 
future research are discussed.
Keywords'. Predictor(s), factor(s), cognitive-behavio(u)ral therapy, chronic pain, 
persistent pain, treatment outcome.
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Introduction
Pain is defined as ‘an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage’ (International 
Association for the Study of Pain, 1979). Chronic or persistent pain is defined as 
continuous, long-term pain that has continued beyond three months, or beyond the 
expected time for healing (Elliott, Smith, Penny, Smith & Chambers, 2000). One in 
seven people in the UK live in persistent pain and one third of UK households are 
affected by persistent pain (Elliott, Smith, Penny, Smith & Chambers, 1999). Persistent 
pain is the most common reason for patients to enter healthcare settings and the most 
common reason given for self-medication (Eccleston, 2001). Persistent pain patients 
who present for treatment are often disabled and report other associated problems, such 
as sleep difficulties and fatigue. It has widespread destructive consequences often 
resulting in a range of emotional problems, such as depression and pain-related fear, and 
it significantly lowers quality of life (Eccleston, 2001).
Treatment options for the management of persistent pain range from invasive surgical 
procedures to use of medications such as opioids and other analgesic agents, alternative 
therapies such as needle acupuncture, and psychological therapies. The costs for 
treating persistent pain are huge, yet we are still a long way from eliminating or 
adequately controlling pain for large numbers of patients in pain (McCracken & Turk, 
2002). Most treatment methods for persistent pain aim to reduce pain, whereas when 
patients are referred to psychological treatment it is often for the purpose of learning
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behavioural and cognitive methods for reducing the experience and impact of pain 
(McCracken, Vowles & Eccleston, 2004). A variety of psychologically based treatment 
approaches have been developed and empirically validated for helping people to manage 
their persistent pain (Osborne, Raichle & Jensen, 2006). For example, treatment 
approaches include operant behavioural therapy and cognitive-behavioural therapy 
(CBT). These approaches aim to enhance quality of life and pain-related coping, and to 
reduce disability and pain-related difficulties with functioning. They are therefore 
rehabilitative approaches and the emphasis is placed on improvement in function despite 
residual pain.
The theory informing a behavioural approach is that pain and pain disability are 
influenced not only by somatic pathology, but also by psychological and social factors. 
The theory informing a cognitive-behavioural approach to persistent pain is that a 
person’s belief about their pain has an impact on both their experience of the pain and on 
the psychological and functional consequences of the pain. Cognitive-behavioural 
theory states that psychological factors such as pain catastrophising, pain-related 
anxiety/fear, and helplessness are associated with increased pain, psychological distress, 
and physical disability. The theory also holds that factors such as self-efficacy and 
acceptance would be associated with decreased pain, psychological distress, and 
physical disability (Keefe, Rumble, Scipio, Giordano & Perri, 2004). A cognitive- 
behavioural formulation of persistent pain therefore implies that a person’s subjective 
experience of pain and their behavioural and emotional state can be altered through the 
manipulation of key cognitive and behavioural elements (Morley & Williams, 2002).
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The treatment of choice for persistent pain is now considered to be CBT (Koes, van 
Tulder & Thomas, 2006; Williams, Nicholas, Richardson, Pither, Justins, Chamberlain, 
Harding, Ralphs, Jones, Dieudonne, Featherstone, Hodgson, Ridout & Shannon, 1993). 
CBT’s principles of active participation, education and guided personal experimentation 
make it relatively easy to incorporate into multidisciplinary pain programmes as inputs 
from other disciplines can be framed as following the principles of CBT (Morley, 2004). 
The focus of treatment should be on the detrimental effects of pain and treatment should 
target the domains of pain experience, mood/affect, existing coping methods, pain 
behaviour, physical fitness, social role functioning, and healthcare behaviour (Eccleston,
2001). The strategies employed in CBT concentrate on emotional, behavioural, and 
social responses to pain, and aim to help patients to increase their feelings of self- 
efficacy regarding control of pain (Dalton & Coyne, 2003). CBT for persistent pain 
incorporates components of education, relaxation, use of cognitive coping strategies, 
pacing, exercise, promotion of a self-management perspective, and reduction of 
analgesic and/or psychotropic drugs that have not proved helpful. In addition, 
behavioural techniques, such as activity scheduling to gradually increase activity levels, 
which has previously been shown to be helpful in the treatment of depression, have been 
applied in the persistent pain field (Winterowd, Beck & Gruener, 2003).
This rehabilitative treatment therefore endeavours to restore optimal physical function, 
mood, and self-management of pain, and to give an individual a more helpful 
understanding of and beliefs about pain and its implications (Williams, Morley & Black,
2002). Its aim is to help patients improve their quality of life by coping better with pain 
rather than by decreasing pain intensity (Williams, 1993). Successful cognitive-
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behavioural treatment of persistent pain is said to ‘produce a patient who describes the 
pain in mild terms, engages in productive and satisfying activity on a daily basis, is free 
of excess emotional suffering, and uses medical resources at a prudent level’
(McCracken & Turk, 2002).
There is good evidence that CBT is generally effective when conducted in group formats 
for diverse patients with persistent pain. For example, the 2004 European Guidelines for 
the management of chronic non-specific lower back pain state that the most promising 
approach seems to be cognitive-behavioural interventions encouraging activity and 
exercise. Similarly, the evidence on treatment of persistent pain from Cochrane and 
other systematic reviews shows that CBT delivered in a multidisciplinary treatment 
progr amme is beneficial and recommended (Koes, van Tulder, & Thomas, 2006).
Morley, Eccleston & Williams (1999) conducted a systematic review and meta-analysis 
of all randomized controlled trials (RCTs) of CBT for persistent pain for adults. They 
compared the effectiveness of cognitive-behavioural treatments with waiting list and 
alternative treatment control conditions and all domains of persistent pain problems with 
sufficient data were coded for effect sizes. Outcome domains were characterised as pain 
experience, mood/affect, positive cognitive coping and appraisal, negative cognitive 
coping and appraisal, behaviour/expression, behaviour/activity, and social role 
performance. They revealed that compared with a no-treatment control, CBT produced 
significant effect sizes with a median of 0.50 across all domains (effect sizes across 
domains ranged from 0.36 to 0.6). CBT also produced significantly greater changes for 
domains of pain experience, cognitive coping and appraisal, and pain behaviour, when
compared to alternative active treatments such as physiotherapy and medical 
management. There was insufficient data on health care use and work status. They 
concluded that active psychological treatments based on the principle of CBT are 
effective for persistent pain in adults.
However, not all patients respond identically to treatment and unfortunately not all 
patients reap the benefits of treatment to the same degree. The observed differential 
effectiveness of CBT has led to studies attempting to identify patient and psychosocial 
variables that influence treatment outcome, in an attempt to understand the impact of 
sources of heterogeneity on treatment outcome. Researchers in the field of persistent 
pain can learn much from research in general mental health. For example, in depression 
research, increasing theoretical model sophistication and design manipulation has 
generated a wealth of information regarding the specific and non-specific factors 
associated with treatment outcome (Hamilton & Dobson, 2002). Such information is of 
concern to treatment providers, to patients on long waiting lists, and to treatment 
funders, and it would facilitate treatment planning, and ultimately increase treatment 
efficiency.
The purpose of this article is to review the available literature on demographic, non­
specific and specific predictors of outcome following CBT for persistent pain. Although 
other sources of variability in therapeutic outcome exist, for example therapist variables, 
such as level of training and adherence to treatment protocol, it is not within the scope of 
this review to address these. The review instead focuses on the variability explained by 
differences between pain patients, differences in process variables, and where possible
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the interaction between these factors. Finally, limitations of the research and directions 
for further studies of predictors of outcome in CBT for persistent pain are provided.
A literature search was conducted for all published studies from 1990 to 2006 on 
variables that influence treatment response to CBT for persistent pain. A computer 
search on PsycINFO and Medline databases was performed to look for articles and 
reviews published using the following keywords: persistent pain, chronic pain, 
cognitive-behavio(u)ral therapy, predictor(s), factor(s), and treatment outcome. In 
addition, reference lists from empirical studies and review articles were perused for 
other relevant information, and a hand search for articles in the journals PAIN, European 
Journal of Pain, and Clinical Journal of Pain was conducted for the years 2000 to 2006. 
Literature was included for review if it was published in the English language, and if it 
focused on predictors of persistent pain outcome in the adult population. All types of 
persistent pain populations were included, except headaches, as the treatment of 
headaches has a different focus (See Grazzi, Usai, & Bussone (2006) for further 
information). All relevant articles from the search are presented. For clarity of 
presentation, the variables examined as potential predictors of treatment response have 
been separated into three categories: personal variables, specific (psychological) factors 
e.g. cognitive change, and non-specific (process) variables e.g. adherence to treatment. 
Many of the studies reviewed examined variables across multiple categories.
Predictors o f CBT Outcomes for Persistent Pain
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It is important to have a note of caution before proceeding, and to keep it in mind when 
reading the review. My concern is that little of the research findings in this area of 
predictors of outcome appear to be derived from theory based hypotheses. Instead, it 
seems that much of the evidence has been found as a result of data mining for findings 
of interest and from post-hoc analyses. Although this method can be valuable to 
highlight areas for further research, results are likely to be specific only to a given 
population and/or treatment and therefore findings may be un-replicable in many cases.
In addition, in carrying out this review in an area where research is sparse, many of the 
studies reviewed have methodological weaknesses. Due to limitations of space, such 
deficiencies will not be discussed for each study individually, but the discussion section 
will comment on issues likely to effect the interpretations that can be drawn from 
studies.
Personal Variables 
Gender
It has been suggested by some researchers that gender differences in response to pain 
management interventions exist, although no theory has been offered to suggest why this 
may be the case. The idea was investigated by Keogh, McCracken and Eccleston (2005) 
using a sample of 98 persistent pain patients (33 males, 65 females), who attended a 3- 
or 4-week residential pain management program. Measures of pain and distress were
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completed pre-treatment, post-treatment and at 3-month follow-up. The study revealed 
that both men and women exhibited significant improvements in ratings of pain post­
treatment. However, at 3-months follow-up it was shown that only men maintained the 
treatment gains, while women showed no significant differences from their pre­
treatment scores. This indicates that men respond better to treatment, but other studies 
have revealed the opposite effect or no significant difference.
Jensen, Bergstrom, Ljungquist, Bodin & Nygren (2001) conducted an RCT using 214 
patients (97 men, 117 women) suffering with long-term, non-specific spinal pain in 
Sweden. They compared treatment as usual, CBT, behavioural orientated physical 
therapy, and combined physical therapy and CBT treatment groups on outcome 
measures of early retirement, sick leave and health-related quality of life (as measured 
by the SF-36, Ware & Sherboume, 1992). Their controlled component analysis found 
that women showed more consistent improvements in health-related quality of life than 
men did.
Williams et al’s (2002) conducted a study of the influences on outcome of pre-treatment 
patient characteristics, treatment characteristics, and their interactions, and looked in part 
at the influence of gender on treatment outcome. The study will be introduced in detail 
here and findings from the study will be recalled here and in various other sections 
throughout this review as necessary.
Williams et al. (2002) utilised data from 1977 persistent pain patients who attended a 
Nation Health Service (NHS) inpatient pain management unit. Patients attended either
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an inpatient programme of 4-weeks or 2-weeks, or a combined inpatient-outpatient 
programme. The age range of patients was 18 years to 84 years old and 63% of the 
sample were female (1245 female, 732 male). The main sites of pain for patients were 
back and/or leg pain (66.2%), upper body pain (23.5%), and pelvic, perineal, genital 
and/or anal pain (10.3%). The mean duration of pain was nine years. Measures of 
depression (measured using the Beck Depression Inventory (BDI); Beck, Ward, 
Mendelson, Mock & Erbaugh (1961)), catastrophising (measured using the 
catastrophising subscale of the Coping Strategies Questionnaire (CSQ); Rosenstiel and 
Keefe (1983), self-efficacy (measured using the Pain Self-Efficacy Questionnaire 
(PSEQ); Nicholas (1989), distance walked in five minutes, and use of drugs were taken 
pre-treatment, post-treatment, at one-month follow-up, and at 6-9 month follow-up.
They used hierarchical (stepwise) regression techniques to analyse each dependent 
variable separately. Regarding the influence of gender on treatment outcome, Williams 
et al. (2002) revealed that being female predicted greater improvement in catastrophising 
at 6-12 months post-treatment, but not on other outcome measures.
Age
In general, older adults benefit from the same psychological interventions and treatments 
have comparable outcomes as with younger adults (Pawlick & Middaugh, 2002). 
However, persistent pain studies have identified differences in treatment outcome which 
could be attributed to age. One hypothesis may be that older people do not make as 
good treatment gains as younger individuals with persistent pain as they are generally 
more likely to have co-morbid conditions, such as having persistent pain and arthritis.
20
People over the age of 65 years old are often excluded from studies conducted in 
America as they are less likely to have health insurance, but the impact of age on 
outcome has been investigated in studies in the UK.
The study by Williams et al. (2002) looked at the impact of age on treatment outcome. 
They showed that younger age was a predictor of better depression scores at one-month 
post-treatment. However, other outcome variables, for example measures of 
catastrophising and walk distance, were not shown to be significantly predicted by age.
Elliott, Smith, Hannaford, Smith & Chambers (2002) later undertook a 4-year follow-up 
study of 2184 individuals living in Grampian, UK, and aimed to describe patterns and 
predictors of change in persistent pain in the community. Participants were asked to 
complete and return by post the chronic pain grade (CPG) questionnaire (Von Korff, 
Ormel, Keefe & Dworkin, 1992), the SF-36 general health questionnaire (Ware, 1992) 
and socio-demographic questions in 1996 and again in 2000. It was therefore a survey 
of self-reported persistent pain in the community. The response rate was 83% at follow- 
up in 2000. Their study revealed that among those with persistent pain at baseline, 
individuals between the ages of 45-74 years were less likely to recover from their 
persistent pain than those aged 25-34 years. Although this is not a treatment study, it is 
included as it provides an insight into how age may be a factor in recovery from 
persistent pain, and highlights the need to investigate age further as a possible predictor 
of treatment outcome. It is worth noting also that the influence of age as a predictor of 
outcome from persistent pain is likely to be confounded by other important factors such 
as duration of pain and acceptance of pain, and these also require investigation.
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M arital Status
It has been suggested that single working mothers differ in their response to health 
treatment compared to married females or to male counterparts (Gatchel, Mayer, Kidner 
& McGeary, 2005). One hypothesis to explain this association is that single working 
mothers have less social support and less time to focus on their own needs than married 
females or male counterparts. One study was found to have investigated this hypothesis.
Gatchel et al. (2005) investigated this hypothesis in their study of 1679 chronically 
disabled work related spinal disorder patients participating in a 5-7 week functional 
restoration program for persistent pain. Psychosocial variables were measured pre- and 
post-treatment, and a structured clinical interview was conducted at 1-year follow-up to 
evaluate long-term outcome. In contrast to what was expected, their study revealed that 
no differences in levels of depression or pain severity were shown at follow-up between 
single working mothers and other patients. This indicates that single parent patients can 
make similar treatment gains to married females or to males.
Minority Group Status
No research investigating the potential role of ethnicity to treatment outcome was found 
in the area of persistent pain. Research in this area is potentially complicated by issues 
of diversity and small numbers, as well as by lack of theory about what factors to do 
with ethnicity may be important. For this reason it would be difficult to interpret any
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findings. For example, it would be unknown whether treatment success may be affected 
by factors such as first language spoken, health beliefs, or access to health care, all of 
which may vary among clients of different minority groups. Research in this area is 
necessary to begin to answer these questions.
Socioeconomic Status (SES)
Education level, occupation and income are most frequently used as measures of SES. It 
is hypothesised that socioeconomic disadvantage may have a negative impact on 
persistent pain treatment outcome as motivation levels to return to work may be reduced 
in this population as they have less rewarding jobs and poorer incomes. A number of 
studies have investigated the role of SES on treatment outcome.
Williams et al. (2002) found that longer education was a variable that predicted better 
scores on catastrophising short-term, and better scores on self-efficacy and walk distance 
at long-term follow-up. They also found that being at work at the start of treatment 
predicted better scores on a measure of self-efficacy short-term, and on a measure of 
depression at long-term follow-up. However, these results were found through data 
mining and post-hoc analyses, rather than via theory-driven hypothesis testing.
More recently, Hankin and Killian (2004) researched the extent to which demographic, 
psychological, and readiness to change indicators predicted functional outcomes in 
patients with persistent pain. Their prospective study used data from 26 persistent pain 
patients. The Pain Disability Index (PDI; Tait, Pollard, Margolis, Duckro & Krause,
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1987) and the Pain Patient Profile (P-3; Tollison, 1993) were completed pre-treatment 
and at 3-months into treatment. Regression analyses indicated that work status and 
being in the contemplation stage of readiness to change at baseline accounted for 49% of 
the variance in functional outcome at 3-month follow-up. Results from this study must 
however be interpreted cautiously due to the very small sample size used, as small scale 
studies tend to over-estimate effects.
Social Support
It has been hypothesised that social resources in terms of amount of social support may 
have lasting effects on functional disability and levels of pain in persistent pain patients 
and a number of studies have demonstrated an association between higher levels of 
social support and lower levels of chronic pain. For example, in a study by Jamison and 
Virts (1990), patients with chronic pain reported their perceptions of family support 
prior to entering an outpatient pain programme. At follow-up, one year following the 
completion of the programme, it was discovered that patients who initially reported 
having supportive families reported significantly less pain intensity, less reliance on 
medication and greater activity levels.
Another study by Tota-Faucette, Gil, Williams, Keefe & Goli (1993) aimed to identify 
that family factors, including amount of social support, may influence treatment 
outcome. They showed that patients whose families were less supportive, more 
controlling and less cohesive made fewer treatment gains than others. Also, Radojevic, 
Nicassio & Weisman (1992) conducted a RCT study on rheumatoid arthritis patients
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experiencing chronic pain. Patients were assigned to four treatment groups: CBT; CBT 
with family support; education with family support group; and a no treatment group. 
Measures of level of pain, disease activity and psychological status were taken during 
treatment and at 2-months follow-up. The study revealed that the intervention with 
family support produced improved outcome at post-treatment compared to all other 
conditions. They reported that spousal participation in treatment tended to enhance 
outcome in rheumatoid arthritis patients and concluded that it is useful to include family 
members in pain treatment.
Another later study by Evers, Kraaimaat, Geenen, Jacobs & Johannes (2003) also 
investigated this hypothesis using 78 patients with rheumatoid arthritis. They examined 
the role of pain coping and social support at the time of diagnosis in relation to outcome 
after three and five years. Their study revealed that low levels of social support at the 
time of diagnosis consistently predicted both more functional disability and increased 
pain at follow-up. Therefore they again revealed social support to have a positive 
impact on outcome. They believed that their results supported the proposition that early 
interventions should target the social resources of patients in an effort to influence long­
term outcome in rheumatoid arthritis.
Each of the above studies indicates that social support is beneficial to persistent pain 
sufferers in terms of their overall health. It is worth considering that according to 
behavioural theory social support would instead be viewed as disabling in relation to 
pain. One hypothesis based on this theory may suggest that an individual with good 
social support may not be motivated to continue using self-management coping skills or
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to build on their physical progress, and would therefore have a poorer outcome.
However, the reviewed studies do not support this hypothesis.
Compensation Claim and Disability Pension
Persistent pain patients in the process of applying for a compensation claim or those 
receiving a disability pension are believed to be less likely to show improvements on 
outcome measures post-treatment. Such a hypothesis is based on the assumption that 
secondary gain factors may play a role in maintaining a patient’s difficulties. A number 
of studies have been conducted to investigate such a claim.
Confirming the earlier work of Mendelson (1992), who was interested in the relationship 
between compensation and chronic pain, Vaccaro, Ring, Scuderi, Cohen & Garfin 
(1997) reported that treatment outcome from surgical management of chronic low back 
pain was negatively affected if compensation or litigation proceedings were being 
pursued. A further study by Rainville, Sobel, Hartigan & Wright (1997) investigated the 
effect of compensation involvement on the reporting of pain and disability by 192 
patients referred to a spine rehabilitation programme for chronic low back pain. They 
also showed that compensation involvement had an adverse effect on self-reported pain, 
depression, and disability, both before and after treatment.
In addition, Becker, Hojsted, Sjogren & Eriksen (1998) conducted a study in Denmark 
to investigate whether non-malignant persistent pain patients receiving or applying for 
disability pension benefit from multidisciplinary treatment. They focussed on the impact
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that receiving or applying for disability pension benefit may have on outcome in 286 
patients. They found that retirement pension and disability pension status significantly 
predicted outcome. For example, patients on retirement pension, who were over the age 
of 68 years, showed a significantly larger reduction in pain than those not receiving 
pensions, who were younger. They also showed that patients receiving a disability 
pension improved as much as those not receiving a disability pension. By contrast, 
patients applying for disability pension were shown not to improve when compared to 
patients already receiving disability pension. In fact they were found to show a decline 
in functioning.
Diagnostic Status
Diagnostic status in this case refers to what pain diagnosis patients have, for example 
rheumatoid arthritis or non-specific lower back pain. No theory was found in the 
literature from which hypotheses on the expected influence of diagnostic status on 
treatment outcome could be based. In addition, diagnostic status is not generally 
described or investigated in patients with persistent pain as no satisfactory or reliable 
system of diagnoses exists (Wall (p 1-7), In Wall & Melzack, 1994). However, one 
study was found to have investigated the possible association.
Hildebrandt, Pfingsten, Saur & Jensen (1997) studied potential factors associated with 
success from a multidisciplinary treatment programme for chronic back pain patients. 
Ninety chronic low back pain patients who were admitted to an 8-week programme of 
functional restoration and behavioural support were recruited for the study, although
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only 82 were available at follow-up. Outcome measures were taken pre- and post­
treatment, and at 6 and 12-months follow-up and included an assessment of pain 
intensity and pain disability, return to work, and measurement of strength and general 
endurance. From analysis they concluded that medical background (duration of pain, 
surgical procedures), medical diagnosis, and physical impairment variables appeared to 
have little influence on treatment outcome.
Previous Treatment
The mean duration of pain reported by patients treated at pain clinics exceeds 7 years 
(Eccleston, 2001), and so patients have commonly undergone a large number of 
previous treatments at the point where they enter a programme for psychological 
treatment. The number and type of previous treatments for persistent pain that a patient 
has engaged in may be one of the most important factors influencing treatment outcome. 
This is because the success or failure of previous treatments may have a powerful effect 
on a patient’s beliefs and self-efficacy. For example, if a patient has had a number of 
failed previous treatments, their beliefs about the pain and hopes for its management are 
more likely to be negative e.g. ‘I have no control over my pain’, and it may therefore be 
more difficult to engage the patient in self-management.
Barnes, Smith, Gatchel & Mayer (1989) looked at psychosocioeconomic predictors of 
treatment outcome in 150 chronic low back pain patients following a 3-week functional 
restoration rehabilitation programme. They aimed to identify possible factors associated 
with treatment success or failure, at 1- and 2-year follow-up. The Millon Behavioural
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Health Inventory (MBHI; Millon, Green & Meagher, 1982), the BDI, self-report indices 
of pain and disability, and socioeconomic and demographic information were utilised in 
the study. Also, variables such as the number of prior spinal surgeries were examined as 
it was hypothesised that these would influence participation in an active rehabilitation 
setting and therefore may influence treatment response. Patients were divided into three 
outcome groups (success, failure, and dropout) based on outcome criteria, and then 
analyses aimed to show whether certain variables could predict outcome group. They 
revealed that the number of previous spine surgeries a person had was predictive of 
worse outcome. Barnes et al. (1989) suggest that this may be because during treatment, 
surgery may remain a viable treatment option in the patients’ minds, and so as the 
activity demands of treatment increase they may be more tempted by a surgical cure.
Summary
In summary, many personal and medical variables have been examined with the aim of 
identifying possible predictors of treatment outcome. It can be seen that some variables 
have been investigated as possible predictors of outcome by many studies, while other 
variables have been left poorly researched or not researched at all.
The review has shown that the influence of the variables of age, marital status, and 
minority group status on treatment outcome has been under researched. For that reason, 
no firm conclusions can be drawn from the literature regarding the role of these 
demographic variables in predicting treatment outcome.
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For variables where more research was available for review, in general, findings across 
different studies are shown to be inconsistent, and the possibility of any particular 
variable being a predictor of treatment outcome therefore appears to remain unclear. For 
example, the proposed association between gender and treatment outcome has not been 
shown to be theory driven, and results across studies are not in agreement. However, 
gender may be a variable that influences other predictors of outcome, i.e. it moderates 
the relationship between other variables and treatment outcome, as indicated by 
MacFarlane, Thomas, Croft, Papageorgiou, Jayson & Silman (1999). The role of gender 
as a moderating variable for treatment outcome therefore warrants further investigation.
However, this review showed that the variables of SES, social support, and applying for 
compensation or disability pension constantly predicted outcome in the reviewed 
studies. These findings contrast with those of Hamilton and Dobson (2002). Their 
review of predictors of response to cognitive therapy (CT) for depression found that 
from all demographic variables only marital status was found to be a significant 
predictor of response to treatment.
Specific Variables
The roles of a large number of psychological constructs (e.g. level of depression, 
treatment expectancy beliefs, and catastrophising) on chronic pain treatment outcome 
have been investigated in recent years, the most researched of which will be presented 
here. A review of the literature revealed that researchers tend to have defined 
psychological constructs in different ways (e.g. negative affect vs. depression), and
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showed that many constructs overlap. This made it difficult to summarise the findings 
in this area into distinct categories and so overlaps between the categories may exist.
Depression
Depression is one of the most frequently hypothesised and tested influences on 
persistent pain outcome (e.g. Bums, Johnson, Mahoney, Devine & Pawl, 1998; Malone 
& Strube, 1988). However, for clarity just two of the most cited studies are reviewed in 
more detail, as they illustrate the inconsistency amongst findings. These studies aimed 
to test the hypothesis that symptoms of depression mediate treatment response for 
persistent pain patients, as individuals with high levels of depression have maladaptive 
appraisals and are believed to be less likely to engage in and use the cognitive and 
behavioural strategies introduced to them over the course of therapy.
Dworkin, Richlin, Handlin & Brand (1986) investigated this hypothesis in an early study 
when they aimed to test whether short-term and long-term treatment responses in 
depressed and non-depressed chronic pain patients differed. A sample of 454 chronic 
pain patients was included in the study looking at short-term improvement. A sub­
sample of 82 patients were contacted by telephone an average of 18-months after the 
beginning of treatment to gather long-term follow-up data on treatment response. 
Treatment response for each patient was rated on a five point scale, from none to 
complete improvement. These ratings were made based on the patient’s pain complaint, 
activity level, and medication use. The study revealed that short-term and long-term 
treatment responses for patients with persistent pain, who also experienced depression
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(diagnosed using DSM-II criteria), did not differ significantly from persistent pain 
patients not experiencing depression. However, it was shown that short-term treatment 
response in these two groups of pain patients was predicted by different patterns of 
variables. Predictors of good treatment outcome for non-depressed patients were found 
to be increased treatment visits, fewer previous treatments for their persistent pain, pain 
being located in the lower back area rather than other locations, and patients not 
receiving worker’s compensation benefits. In contrast, outcome for persistent pain 
patients suffering with depression appeared to be influenced by employment status at the 
beginning of treatment (better to be employed) and the duration of persistent pain (the 
shorter the better).
Lofland. Bums, Tsoutsouris, Laird, Blonsky & Hejna (1997) later conducted a study 
looking at predictors of outcome following multidisciplinary treatment of persistent 
pain, looking specifically at the effects of changes in perceived disability and depression 
on treatment outcome. One hundred and twenty eight persistent pain sufferers admitted 
to a multidisciplinary pain management programme were originally asked to participate 
in the study, but the final sample included was 82 patients, due to non-attendance and 
missing measures. In contrast to the findings of Dworkin et al. (1986), their study 
showed that decreased depression and decreased perceptions of disability each made 
significant contributions to improvement in pain severity. Decreased depression also 
significantly predicted improvement in daily activity.
Pain Beliefs
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The cognitive-behavioural approach to pain management assumes that it is cognitive 
change which underlies the other changes that occur following treatment (Williams et 
al., 1993). It is hypothesised according to the CBT approach that the effectiveness of 
pain management programmes is attributable to their influence on pain-related beliefs. 
The umbrella term of ‘pain beliefs’ is used here to incorporate the following variables: 
self-efficacy of pain; fear of pain or re/injury; pain tolerance; pain helplessness; pain 
catastrophising; and perceived disability. Each of these will be discussed in turn.
Richardson and Richardson (1999) examined whether cognitive change mediated 
successful treatment outcome following cognitive-behavioural pain management in a 
sample of 833 severely impaired persistent pain patients. They used the Pain Cognitions 
Questionnaire (PCQ: Boston et al., 1990), a self-rated measure of pain-related 
cognitions, to examine if change in the PCQ pre- to post-treatment was predictive of 
levels of pain, depression, medication use and general functioning at one-month follow- 
up. They revealed that cognitive change accounted for up to 15% of the variance in 
outcome and concluded that the study provided supportive evidence for the influence of 
cognitive change on outcome from cognitive-behavioural pain management.
A study by Bums, Glenn, Bruehl, Harden & Lofland (2003) used a cross-lagged panel 
design to investigate whether early treatment cognitive change predicted late treatment 
index change, but not vice versa. Based on other psychological findings, they aimed to 
determine whether the process of cognitive change is an active therapeutic ingredient of 
treatment programmes, while controlling for depression change. Their study was 
conducted using 90 persistent pain patients from a 4-week intensive multidisciplinary
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programme. Measures of catastrophising, pain helplessness, depression, pain, 
interference, and activity level were taken pre-treatment (1 week before the programme 
began), mid-treatment (5th day of second week) and post-treatment (5th day of forth 
week). Findings suggested that early treatment catastrophising (as measured by the 
Catastrophising Subscale (CS) of the Coping Strategies Questionnaire; Rosentiel & 
Keefe, 1983) and pain helplessness changes (as measured using an adapted version of 
The Arthritis Helplessness Index; Nicassio, Wallston, Callahan, Herbert, & Pincus,
1985, in which the authors substituted the word arthritis with the word pain) predicted 
late-treatment outcome (as measured by the Multidimensional Pain Inventory; Kerns, 
Turk, & Rudy, 1985), but not vice versa, even with changes in depression controlled for. 
This indicates that cognitive changes during treatment have a significant effect on 
treatment outcome, regardless of changes in level of depression. They showed that pain 
helplessness reduction predicted less than 10% of the variance in outcome gains.
Bums, Kubilus, Bruehl, Harden & Lofland (2003) later replicated and extended their 
investigation of the role of cognitive factors contribution to treatment outcome in 
persistent pain patients. 65 patients who entered a 4-week multidisciplinary programme 
for the treatment of their persistent pain participated in the study. Bums et al. (2003) 
revealed that early-treatment reductions in catastrophising and pain-related anxiety 
predicted late-treatment improvements in pain severity, but not vice versa. Further 
support that cognitive change may influence treatment changes in outcome has come 
from the study of randomised control trials.
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A study by Smeets, Vlaeyen, Kester & Knottnerus (2006) offers further support for this 
hypothesis. 211 patients with non-specific chronic low back pain took part in their 
randomised control design study. Using four treatment groups: active physical 
treatment; CBT; combined active physical treatment and CBT; and waiting list control, 
they investigated whether treatments based on different theories changed pain 
catastrophising and internal control of pain. They also examined whether changes in 
these factors mediated treatment outcome. Participants in all three active treatment 
groups were found to decrease on the measure of pain catastrophising and were shown 
to improve on the measures of pain experience. It was further implied that change in 
pain catastrophising mediated the reduction of disability, pain complaints, and pain 
intensity. In the active physical treatment group only, pain catastrophising was also 
found to mediate the reduction in depression. Smeets et al. (2006) concluded that pain 
catastrophising can be reduced even when it is not a direct target of therapy and that 
changes in pain catastrophising mediate treatment outcome.
Spinhoven, Kuile, Kole-Snijders, Mansfeld, Ouden & Vlaeyen (2004) conducted a study 
to examine whether changes in pain coping and cognition during multidisciplinary 
treatment for chronic low back pain mediated treatment outcome. They tried to improve 
on methodology from previous studies such as Jensen et al. (2001) by including a no­
treatment control group and other forms of active treatment. It was hypothesised that 
changes in pain and adjustment to pain would be mediated by an enhanced perceived 
internal control of pain and a reduction in catastrophising of pain. Their RCT, involving 
148 patients, revealed that the operant-behavioural treatment plus cognitive coping skills 
training group resulted in a short-term and long-term decrease in catastrophising and an
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enhancement of internal pain control. They further identified that changes in 
catastrophising and internal pain control mediated the reduction in level of depression 
and pain behaviour following treatment. This study corroborates that having a focus on 
decreasing catastrophising thoughts and promoting internal expectations of pain control 
during treatment is important to bring about change.
Malone and Strube (1988) earlier hypothesised that reducing patients’ fear of pain, 
rather than reducing the pain itself, should be the key aim of psychological treatments. 
McCracken and Gross (1998) later studied the role of pain-related anxiety reduction in 
the outcome of a 3-week multidisciplinary treatment programme for 79 chronic low 
back pain patients. They found that decreased pain-related anxiety significantly 
predicted improvement on a range of outcomes, including measures of pain severity, 
disability level, general affective distress and level of daily activity. Change in pain- 
related anxiety was identified to explain the variance in outcome even when controlling 
for change in depression. They concluded that resolution of fear is the key to success 
and reductions in pain-related fear predict improved treatment outcomes.
McCracken & Turk (2002) went on to conduct a follow-up study and showed that the 
role of reduced pain-related anxiety in treatment outcome was independent of change in 
physical capacity. They found that changes in pain-related anxiety during treatment 
accounted for more variance in the prediction of outcome than change in physical 
capacity. This casts doubt on the hypothesis that patients should adhere to doing 
exercises following treatment, as if a client becomes more active on a daily basis another 
model is that they would no longer need to do the prescribed exercises.
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Lofland et al. (1997) looked at whether changes in perceived disability accounted for the 
variance in pre- to post-treatment improvements in outcome variables in 82 patients 
receiving multidisciplinary treatment for persistent pain. Regression analyses revealed 
that change scores on the measure of perceived disability (the Pain Disability Index) 
predicted unique variance in pain severity (as measured by the Pain Severity Subscale of 
the Multidimensional Pain Inventory) and functional level changes (patients’ abilities to 
lift, carry, push, and pull weights as evaluated on a scale of 1 to 8). This result stood 
when controlling for changes in depression. The authors concluded that improvements 
in outcome variables may be mediated by decreases in perceived disability.
Hildebrandt et al.’s (1997) study also looked at the role of perceived disability on 
treatment outcome on chronically disabled low back pain patients who completed an 8- 
week functional restoration and behaviour support programme. They again identified 
that successful treatment outcome was predicted most clearly by a reduction in patients’ 
subjective feelings of disability.
Finally, Burns et al. (1998) investigated whether cognitive and physical capacity 
changes that occur through multidisciplinary pain treatment contribute uniquely to long­
term treatment outcome. 94 persistent pain patients participated in the study and 
measures of pain helplessness, lifting capacity, walking endurance, depression, pain 
severity, and activity levels were collected at three time points: pre-treatment; post­
treatment; and 3- to 6-months follow-up. Evidence for the contribution of cognitive 
changes to long-term outcome was indicated as decreases in pain helplessness (as
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measured by an adapted version of the Arthritis Helplessness Index) were found to be 
linked to reductions in pain severity (as measured by the Pain Severity subscale of the 
Multidimensional Pain Inventory). These results were shown even after controlling for 
the effects of depression decreases, indicating that decreases in pain helplessness makes 
a unique contribution to long-term outcome.
Acceptance o f Pain
Few studies have addressed acceptance of pain as a variable influencing treatment 
outcome. However, a number of cognitive and behavioural therapies, such as 
mindfulness-based stress reduction (MBSR), have begun to focus on acceptance of pain 
as a factor that influences outcome. ‘Acceptance’ is defined as “experiencing events 
fully and without defence, as they are” (p.30, Hayes, Jacobsen, Follette, & Dougher, 
1994), and ‘acceptance of pain’ is defined as acknowledging that you have pain, giving 
up unproductive efforts to control it, and acting as if pain does not imply disability 
(Hayes, Jacobson, Follette & Dougher 1994). Baer’s (2003) review of empirical 
research on the utility of mindfulness based interventions identified four studies that had 
examined the effects of MBSR on patients with persistent pain. In general, findings 
revealed significant improvements and maintenance of improvements at follow-up, 
indicating that acceptance of pain may be an important variable in the prediction of 
treatment outcome.
A study by McCracken (1998) investigated the role of acceptance of pain on outcome 
using 160 chronic pain patients attending a university pain management centre. Self­
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report measures including the Chronic Pain Acceptance Questionnaire, the BDI, the Pain 
Anxiety Symptom Scale, and the Sickness Impact Profile were used as measures of pain 
acceptance, level of depression, level of pain-related anxiety, and level of disability 
respectively. The study showed that greater acceptance of pain was found to be related 
to lower reports of pain, less pain-related anxiety and avoidance, less depression and 
disability, and better work status. More recently, acceptance of persistent pain has also 
been associated with fewer healthcare visits for pain, and fewer cases of prescribed 
analgesic medications (McCracken et al., 2004).
Treatment Expectancy
Patients’ pre-treatment beliefs in the success of treatment have been shown to be one of 
the strongest predictors of final treatment outcome in psychotherapy research (Kirsch, 
1999), but their role have only recently been attended to in the area of persistent pain. 
Treatment expectancy has been referred to as the strength of expectation that 
improvements will be achieved during treatment (Goosens, Vlaeyen, Hidding, Kole- 
Snijders & Evers, 2005). The hypothesis that treatment expectations have an impact on 
treatment outcome states that the patients’ beliefs about what they think they can do are 
powerful predictors of actual functioning (Lackner, Carosella & Feuerstein, 1996).
Kole-Snijders, Vlaeyen, Goossens, Rutten-van Molken, Heuts, van Breukelen & van 
Eek (1999) conducted an RCT investigating the role of treatment expectancy on 
outcome in patients with chronic low back pain following CBT. 148 patients 
participated in the study and were assigned to an operant behavioural treatment and
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cognitive coping skills training group, an operant behavioural treatment and discussion 
group, or a waiting list control group. Self-report and observational measures of pain 
behaviour, pain cognitions, activity tolerance, pain intensity, and negative affect were 
taken pre-treatment, post-treatment, at 6-month follow-up, and at 12-month follow-up.
In addition, treatment credibility was measured at the start and end of treatment through 
patients rating their personal belief that the programme would help them cope better 
with pain on a visual analogue scale ranging from ‘not at all’ to ‘very much’. Patients’ 
certainty score in the belief was then rated on a 5-point likert scale. Total credibility 
score was calculated as a product of their belief and certainty scores. Results showed 
that treatment credibility ratings were important predictors of successful outcome, as 
measured by self-reported pain coping and control, and observed activity tolerance and 
pain-behaviour at follow-up. Patients who believed in the credibility of treatment at the 
beginning of treatment were shown to improve more on motoric behaviour and coping 
control immediately after treatment.
Similarly, Williams et al. (2002) examined the influence of pre-treatment variables on 
treatment outcome and found that patients’ expectations of treatment benefit contributed 
to outcome prediction. Also, Morley, Hussain & Williams (2005) used a sample of 1013 
persistent pain patients to investigate the influence of generic pre-treatment expectation 
of change on CBT treatment outcome measures measured at three time points: pre­
treatment; 1-month post treatment; and at 6, 9 or 12 months follow-up. Using multiple 
regression methods they revealed that pre-treatment expectations had a significant 
impact (although it explained less than 5% of the variance) on levels of pain 
interference, levels of depression and physical capacity.
Furthermore, a study by Goossens et al. (2005) corroborated these findings. They aimed 
to examine whether patients’ initial beliefs about the effectiveness of a given pain 
treatment influenced the final treatment outcome in patients with chronic low back pain 
or fibromyalgia. The extent to which treatment expectancy (as measured by a short self- 
report questionnaire) predicts the short-term and long-term outcome of cognitive- 
behavioural treatment for persistent pain was investigated employing the data of two 
pooled randomised control trials. Data from a total of 171 patients were available for 
the analysis. The analyses showed that patients with higher treatment expectancies 
received significantly less disability compensation and were less fearful. In addition, 
pre-treatment expectancy was shown to predict a small amount of variance in the four 
outcome measures (pain coping and control, motor behaviour, negative affect and 
quality of life) immediately post-treatment. The significant explanatory contribution of 
the pre-treatment expectancy score varied between 1% and 8%. Pre-treatment 
expectancy scores were also shown to predict motor behaviour, negative effect, and 
quality of life at 12-month follow-up. They concluded that assessing patients’ 
expectations for CBT for their pain is necessary prior to entering treatment.
Summary
In summary, the review indicates that many studies have investigated the role of specific 
factors on treatment outcome and findings across studies have largely been shown to be 
compatible.
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Changes in catastrophising, self-efficacy, pain-related fear, pain tolerance, pain 
helplessness and perceived disability have each been shown to consistently predict 
outcome. In addition, acceptance of pain, treatment expectancy, and levels of 
depression have each been indicated as important influences on treatment outcome. The 
findings show the importance of psychological variables on treatment outcome, and 
indicate that they should be a target on treatment.
Non-specific Variables
As the name suggests, CBT aims to bring about change in a person’s thoughts and 
behaviours. The assumption that it is important to bring about behavioural change, 
either directly or indirectly via cognitive change, has been justified in other fields such 
as in the treatment of depression. In the field of persistent pain, behavioural change is 
considered as an outcome or target of treatment (e.g. increases in levels of activity, and 
improved physical and social functioning), and as a process variable influencing 
outcome (e.g. adherence to treatment recommendations). As yet it is unclear how much 
emphasis should be targeted towards behavioural change as a process variable in the 
management of persistent pain.
Adherence during treatment
Adherence during treatment refers to the undertaking of recommended behaviours (e.g. 
pacing, and relaxation) during the treatment period. Jensen, Turner & Romano (1994) 
investigated correlates of improvement in multicomponent treatment of persistent pain
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using 94 persistent pain patients. They were interested in part in testing the relationships 
between treatment outcome and use of behavioural coping strategies. Behavioural 
coping strategies were measured using a questionnaire on which patients had to indicate 
the number of days in the preceding seven in which they had used strategies of exercise, 
pain-contingent rest, keeping busy, opioid medication use, and relaxation. Outcome 
measures of psychological functioning (measured using the BDI), physical functioning 
(measured using the Physical Dysfunction scale of the Sickness Impact Profile), and use 
of medical services (measured as number of self-reported pain-related healthcare 
contacts) were taken pre-treatment and 3-6 months post-treatment. They showed that 
increased use of behavioural coping strategies developed during the course of treatment 
did not explain significant amounts of improvement on outcome. Instead their study’s 
findings implied that only changes in maladaptive and negative beliefs (measured using 
the Survey of Pain Attitudes) were critical in improving treatment outcome.
More recently, Heapy, Otis, Marcus, Frantsve, Janke, Shulman, Bellmore & Kerns 
(2005) investigated the hypothesis that adherence to treatment between sessions 
mediated the relationship between readiness to change and goal accomplishment in 
persistent pain patients. A measure of readiness to adopt a self-management approach to 
persistent pain, aggregated intersession adherence ratings, and mean post-treatment goal 
accomplishment ratings were gathered for 78 pain patients. Results indicated that pre­
treatment readiness to change significantly predicted intersession adherence and goal 
accomplishment. Furthermore, the relationship between readiness to change and goal 
accomplishment was significantly enhanced when adherence between sessions was 
taken into account, indicating that adherence to therapist recommendations for coping
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skill practice mediates readiness to change and self-reported goal attainments. However, 
it is worth noting that as the goal attainments measure is self-reported, it may simply be 
tapping the same construct again.
Adherence to Behaviour Changes after Treatment
Adherence with therapeutic recommendations subsequent to treatment termination may 
be an important predictor of long-term treatment gains. As Turk, Rudy & Sorkin (1993) 
said, ‘For treatment to be effective, the patient must comply with the treatment 
recommendations’. Furthermore, it has been suggested that for chronic difficulties, the 
long-term outcome following brief treatments may be poor (even if their initial response 
is good) unless treatment is maintained over prolonged periods through self­
management, albeit at low intensity (Roth & Fonagy, 1996). That said, limited attention 
has been paid to this issue in the pain literature, the evidence supporting such statements 
is sparse, and any attempts to examine the relationship between adherence and 
maintenance of treatment gains have so far used very simple models.
Turk and Rudy (1991) conducted a review of the literature in which they raised the 
question of the role of continued practice of pain management methods in the 
maintenance of treatment gains. They argue that failure to practice or employ coping 
strategies, exercises, relaxation techniques, and other methods taught during treatment in 
the follow-up period has been shown to contribute to relapse. Their review of studies on 
arthritis and heterogeneous pain clinic patients suggest that adherence and relapse are
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related; however, this association is less well established for other problems such as 
headaches.
Taimela, Diederich, Hubsch & Heinricy (2000) recognised that the role of exercises on 
the long-term success and maintenance of outcome after the guided treatment period has 
ended had not been extensively investigated in chronic low back pain patients. They 
sought to examine to role of adherence to physical exercise on pain recurrence and 
absenteeism from work using 125 patients who had completed a 12-week active low 
back rehabilitation programme. Outcome measures of levels of subjective pain and 
disability were completed 14 months after treatment ended. Results showed that 
recurrences of persistent pain and frequencies of work absenteeism during the follow-up 
period were significantly fewer among those who had maintained regular exercise habits 
since treatment when compared to those who had been physically inactive. They 
concluded that the maintenance of treatment gains following active treatment is 
predicted by adherence to exercises after guided treatment has ended.
Summary
In summary, this area of interest appears under-researched. Few studies were found that 
had investigated the role of adherence during or after treatment on treatment outcome. It 
is important to consider also that finding associations between adherence behaviour and 
behavioural outcomes is to be expected if the measures of each are tapping the same 
thing, for example frequent exercise. The focus thus far appears to be on the impact of
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adherence to behaviours rather than on the influence of adherence to cognitive strategies. 
This would be an exciting area for future research.
Discussion
Summary of Findings
Although CBT is effective in treating a variety of difficulties, not all persistent pain 
patients benefit from this form of treatment. Studies have examined a diverse range of 
variables that may influence treatment outcome. The review has identified that studies 
in the field of persistent pain have investigated a wide range of personal and medical, 
specific and non-specific factors that are believed to have an impact on treatment 
outcome following CBT for persistent pain.
Patient demographic factors identified as potential predictors of treatment outcome were 
SES, social support, and whether a person is applying for compensation or disability 
pension. Other demographic variables were not shown to consistently predict outcome. 
The lack of consistency among research findings means that the current results are not 
sufficient to guide treatment assignment and patient demographic variables therefore 
appear to contribute little.
Findings from studies investigating the role of non-specific variables on outcome were 
also found to be inconsistent across studies. Rather than concluding that these variables 
therefore have little or no impact on treatment outcome, the results must be interpreted
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in light of considerations about the individual studies. Inconsistencies between studies 
may be due in part to disparate patient samples, inconsistent research methodologies, 
variability in treatments offered, different treatment settings, and divergent treatment 
outcome criteria and measurement techniques between studies. For example, the 
participants in the Jensen et al. (1994) study had completed an inpatient 
multidisciplinary pain programme, while the participants in the Heapy et al. (2005) 
study were randomly assigned to three treatment conditions (primary care CBT, CBT, 
and standard care), each of which was provided in an outpatient setting.
In contrast to the findings regarding the influence of demographic and non-specific 
variables on treatment outcome, the findings from research investigating the role of 
psychological factors appear to be more consistent, and specific variables appear to be 
significant predictors of treatment outcome. Specific predictors of treatment outcome 
for persistent pain appear to include self-efficacy, catastrophising, treatment expectancy 
and amount of perceived pain. It also seems that factors such as low level of depression 
and high acceptance of pain are associated with positive treatment outcomes. Patients’ 
own beliefs and expectations about their pain and how it should be treated therefore 
appear to have a considerable influence on treatment outcome.
Limitations
The review has been valuable in summarising the current research findings in this area. 
However, some early studies (e.g. Dworkin et al. 1986) included in this review are out 
dated and are known to be methodologically weak, and yet have been included as they 
are well cited and offer much in an area of little research. Methodological weaknesses
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of individual studies therefore need to be taken into account, and differences in 
methodologies between studies need to be acknowledged. Methodological weaknesses 
and inconsistencies between studies have an impact on the confidence that can be placed 
on the conclusions of individual studies and they make it difficult to make comparisons 
across studies. Limitations in the reviewed studies include that many of the studies used 
unacceptably small sample sizes, used unreliable outcome measures, and used 
correlation designs.
The sample sizes used in the reviewed studies varied enormously. Of particular concern 
is the small sample of 26 individuals used in the study by Hankin and Killian (2004). 
Such a small sample size obviously has implications for the power of the study, and thus 
on the reliability of conclusions drawn from such a study. Another concern is the self- 
reported nature of many of the outcome measures used by studies, which inevitably lead 
to bias in the results. For example, Heapy et al. (2005) used self-reported measures of 
intersession adherence and goal accomplishment, which simply could have tapped the 
same construct. Finally, the correlational nature of many studies data means that no 
conclusions about causal relationships between hypothesised predictors and outcome 
variables can me made. In other words, the fact that variables have been identified to 
account for some of the variance in changes in outcome measures, may simply be the 
result of other causative change processes. Alternative explanations for observed 
findings cannot be ruled out.
Turning now to focus on understanding why few consistent findings were revealed 
across studies, the review highlighted that many demographic and methodological
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differences existed between studies. These may in part explain the lack of consistency in 
findings. For example, differences between studies included that dissimilar treatments 
were offered, different outcome measures were used, the persistent pain populations 
varied, the length of follow-ups differed, and the design of studies were different.
Very different results were revealed from studies depending on whether treatment was 
CBT inpatient (e.g. Williams et al., 2002) or a functional restoration and behaviour 
support programme (e.g. Hildebrandt et al., 1997). Also, findings differed depending on 
whether outcome was defined as level of pain, emotional distress or return to work 
status. For example, Jensen et al. (2001) and Taimela et al. (2000) used early retirement 
and absenteeism from work respectively as their outcome measure, while Williams et al.
(2002) used measures of depression and catastrophising to indicate outcome. It is 
therefore unsurprising that different results were obtained depending on what measure of 
outcome was utilised.
The type of persistent pain population recruited for studies also differed considerably.
For example, Radojevic et al. (1992) focused on arthritis sufferers, while the study by 
Gatchel et al. (2005) used patients with spinal disorder in their research. The length of 
follow-up also varied amongst these, with Radojevic et al. (1992) taking measures of 
outcome at two-month follow-up, while Gatchel et al. (2005) took it at one-year follow- 
up. Again, it is not surprising that such differences in methodologies would impact on 
the current findings.
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Arguably many of the current findings in this area lack replication and demonstration of 
generalisability due to the above methodological weaknesses. Finally, the review has 
highlighted the lack of theory-based hypothesis testing in the research. Instead, many 
post hoc explanations have been offered as a result of data mining for results and 
reporting what seem to be interesting findings. The difficulty with such methodology is 
that findings are unlikely to be replicated by other studies, which was shown to be the 
case with the demographic variables.
Ideas for Future Research
Most studies investigating the relationship between variables and treatment outcome 
have been shown to rely upon relatively simple conceptual models and univariate 
statistical approaches. Investigating the processes of change in outcome needs to 
continue, with the aim of specifying causal relationships.
Better models are needed of what changes and when, to move this area forward. For 
example, researchers need to ask questions such as what can undermine treatment 
efficacy, what might facilitate it, and similar questions of maintaining gains.
Researchers need to develop more precise models of change, aiming to link specific 
outcomes with changes in particular process variables (Morley, 2004). Focused research 
on particular relationships will be vital in the development and specification of statistical 
models and to identify mediators and moderators of change following CBT for persistent 
pain. Future research on the process of treatment improvements in persistent pain will 
therefore need to use more sophisticated designs and analyses, such as crossed-lagged
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panel designs as utilised by Bums et al (2003), to provide information on whether 
changes on process variables precede changes in outcome.
Further research will also need to address and quantify the effects of critical process 
variables, such as patient adherence to treatment, which as yet have been inadequately 
measured and researched. This will have important theoretical and clinical implications. 
For example, if adherence to treatment is found to predict long-term treatment gains then 
it suggests that appropriate maintenance of change components should be included in 
CBT treatments for persistent pain (Eccleston, 2001). This will be an important and 
valuable advance in the field as it will promote long-term behaviour change for adults 
with persistent pain to ensure that gains are maintained and extended after regular 
treatment ends. Until this issue is resolved, clinicians are unable to provide clear 
evidence-based recommendations to patients at the end of treatment.
The review has highlighted the lack of theory-driven hypotheses in this area, therefore 
theory driven research is required in the future to improve our understanding of 
treatment mechanisms. Also, in the current review it has been difficult to compare 
across studies as treatment protocols were different. Standardising treatment protocols 
would therefore facilitate future research. Finally, studies are needed that examine the 
interrelationships among identified predictor variables and outcome of CBT for 
persistent pain in order to better understand how these variables influence outcome. 
Studies need to control for other variables in their analyses of predictors of outcome, as 
otherwise interpretation of results is difficult.
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Conclusion
It is clear that many variables appear to influence response to CBT treatment for 
persistent pain, although the challenge of understanding exactly why patients vary in 
their response to treatment remains. Great steps forward have been taken in recent 
years, having drawn on research findings from mental health fields. That said, 
improving the effectiveness of psychological treatments for persistent pain, and 
identifying procedures essential for therapeutic change, are challenging and yet 
necessary tasks, and further research is needed in this area. Developing a greater 
understanding of the impact and nature of these sources of variability in outcome will be 
an important step forward in the field of persistent pain. This would lead to advances in 
treatment methods, which in turn will lead to cost savings for the NHS and improvement 
in treatment outcome and patient satisfaction.
Williams and McCracken (In: Asmundson, Vlaeyen & Crombez, 2004) concluded that 
findings about predictors of treatment outcome are not yet able or ready to offer firm 
guidance on treatment-related decisions, and the findings of this current review confirm 
this status. Further research is necessary as results will improve our understanding of 
treatment mechanisms, and will in turn help match patients to effective and appropriate 
treatment, which will help to control treatment costs.
52
References
Baer, R. A. (2003). Mindfullness training as a clinical intervention: A conceptual and 
empirical review. Clinical Psychology: Science and Practice, 10 (2), 125-143.
Barnes, D., Smith, D., Gatchel, R. J. & Mayer, T. G. (1989). Psychosocioeconomic 
predictors of treatment success/failure in chronic low back pain patients. Spine, 14, 427- 
430.
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J. & Erbaugh, J. (1961). An inventory 
for measuring depression. Archives o f General Psychiatry, 4, 561-571.
Becker, N., Hojsted, J., Sjogren, P. & Eriksen, J. (1998). Sociodemographic predictors 
of treatment outcome in chronic non-malignant pain patients. Do patients receiving or 
applying for disability pension benefit from multidisciplinary pain treatment? Pain, 11 
(3), 279-287.
Bums, J. W., Johnson, B. J., Mahoney, N., Devine, J. & Pawl, R. (1998). Cognitive and 
physical capacity process variables predict long-term outcome after treatment of 
persistent pain. Journal o f Consulting and Clinical Psychology, 66, 434-439.
Bums, J. W., Glenn, B., Bruehl, S., Harden, R. N. & Lofland, K. (2003). Cognitive 
factors influence outcome following multidisciplinary persistent pain treatment: a 
replication and extension of a cross-lagged panel analysis. Behaviour Research and 
Therapy, 41 (10), 1163-1182.
Bums, J. W., Kubilus, A., Bruehl, S., Harden, R. N. & Lofland, K. (2003). Do changes 
in cognitive factors influence outcome following multidisciplinary treatment for 
persistent pain? A cross-lagged panel analysis. Journal o f Consulting and Clinical 
Psychology, 71, 81-91.
Dalton, J. A. & Coyne, P. (2003). CBT: tailored to the individual. Nursing Clinics o f 
North America, 38 (3), 465-476.
Dworkin, R. H., Richlin, D. M., Handlin, D. S. & Brand, L. (1986). Predicting treatment 
response in depressed and non-depressed persistent pain patients. Pain, 24, 343-353.
Eccleston, C. (2001). Role of psychology in pain management. British Journal o f 
Anaesthesia, 87 (1), 144-152.
Elliott A. M., Smith, B. H., Penny, K. J., Smith, W. C. & Chambers, W. A. (1999). The 
epidemiology of chronic pain in the community. Lancet, 354, 1248-52.
53
Elliot, A. M., Smith, B. H., Hannaford, P. C., Smith, W. C. & Chambers, W. A. (2002). 
The course of persistent pain in the community: results of a 4-year follow-up study.
Pain, 99(1-2), 299-307.
Elliott, A. M., Smith, B. H., Penny, K. I., Smith, W. C. & Chambers, W. A. (2000). 
Chronic Pain. The Lancet, 355, 234.
Evers, A. W. M., Kraaimaat, F. W., Geenen, R., Jacobs, J. W. G. & Johannes, W. J.
(2003). Pain coping and social support as predictors of long-term functional disability 
and pain in early rheumatoid arthritis. Behaviour Research and Therapy, 41 (11), 1295- 
1310.
Gatchel, R. J., Mayer, T. G., Kidner, C. L. & McGeary, D. D. (2005). Are gender, 
marital status or parenthood risk factors for outcome of treatment for chronic disabling 
spinal disorders? Journal o f Occupational Rehabilitation, 15 (2), 191-201.
Goossens, M. E. J. B., Vlaeyen, J. W. S., Hidding, A., Kole-Snijders, A. & Evers, S. M. 
A. A. (2005). Treatment expectancy affects the outcome of cognitive-behavioral 
interventions in persistent pain. Clinical Journal o f Pain, 1, 18-26.
Grazzi. L., Usai. S., & Bussone. G. (2006). Chronic headaches: pharmacological and 
non-pharmacological treatment. Neurological Science, 27 (2), 174-8.
Hamilton, K. E., & Dobson, K. S. (2002). Cognitive therapy of depression: Pretreatment 
patient predictors of outcome. Clinical Psychology Review, 22, 875-893.
Hankin, H. A. & Killian, C. B. (2004). Prediction of functional outcomes in patients 
with persistent pain. Work, 22 (2), 125-130.
Hayes, S. C., Jacobson, N. S., Follette, V. M., & Dougher, M. J. (Eds.). (1994). 
Acceptance and change: Content and context in psychotherapy. Reno, NV: Context 
Press.
Heapy, A., Otis, J., Marcus, K. S., Frantsve, L. M., Janke, E. A., Shulman, M., Bellmore, 
W. & Kerns, R. D. (2005). Intersession coping skill practice mediates the relationship 
between readiness for self-management treatment and goal accomplishment. Pain, 118, 
360-368.
Hildebrandt, J., Pfingsten, M., Saur, P. & Jansen, J. (1997). Prediction of success from a 
multidisciplinary treatment program for chronic low back pain. Spine, 22 (9), 990-1001.
International Association for the Study of Pain. (1979) - www.iasp-pain.org
Jensen, M. P., Turner, J. A., & Romano, J. M. (1994). Correlates of improvement in 
multidisciplinary treatment of persistent pain. Journal o f Consulting and Clinical 
Psychology, Vol 62 (1), 172-179.
54
Jensen, I. B., Bergstrom, G., Ljungquist, T., Bodin, L. & Nygren, A. L. (2001). A 
randomized controlled component analysis of a behavioural medicine rehabilitation 
program for chronic spinal pain: are the effects dependent on gender? Pain, 91, 65-78.
Jensen, M. P., Nielson, W. R. & Kerns, R. D. (2003). Toward the development of a 
motivational model of pain self-management. Journal o f Pain, 4, 477-492.
Keefe, F. J., Rumble, M. E., Scipio, C. D., Giordano, L. A. & Perri, L. M. (2004). 
Psychological aspects of persistent pain: Current state of the science. The Journal o f 
Pain, 5(4), 195-211.
Keogh, E., McCracken, L. M. & Eccleston, C. (2005). Do men and women differ in their 
response to interdisciplinary persistent pain management? Pain, 114 (1-2), 37-46.
Kerns, R. D., Turk, D. C., & Rudy, T. E. (1985). The West Haven-Yale 
Multidimensional Pain Inventory (WHYMPI). Pain, 23, 345-356.
Kirsch, I. (1999). How expectancies shape experience. Washington: American 
Psychological Association.
Koes, B. W., van Tulder, M. W., & Thomas, S. (2006). Diagnosis and treatment of low 
back pain. British Medical Journal, 332, 1430-1434.
Kole-Snijders, A. M., Vlaeyen, J. W., Goossens, M. E., Rutten-van Molken, M. P., 
Heuts, P. H., van Breukelen, G. & van Eek, H. (1999). Chronic low-back pain: what 
does cognitive coping skills training add to operant behavioural treatment? Results of a 
randomised clinical trial. Journal o f Consulting and Clinical Psychology, 67, 931-944.
Lackner, J. M., Carosella, A. M., & Feuerstein, M. (1996). Pain expectancies, pain, and 
functional self-efficacy expectancies as determinants of disability in patients with 
chronic low back disorders. Journal o f Consulting and Clinical Psychology, 64, 212- 
220 .
Lofland, K. R., Bums, J. W., Tsoutsouris, J., Laird, M. M., Blonsky, E. R. & Hejna, W. 
F. (1997). Predictors of outcome following multidisciplinary treatment of persistent 
pain: Effects of changes in perceived disability and depression. International Journal o f 
Rehabilitation and Health, 3, 221-232.
MacFarlane, G. L., Thomas, E., Croft, P. R., Papageorgiou, A. C., Jayson, M. I. & 
Silman, A. J. (1999). Predictors of early improvement in low back pain amongst 
consulters to general practice: The influence of premorbid and episode-related factors. 
Pain, 80, 113-119.
Maixner, W., & Humphrey, C. (1993). Gender differences in pain and cardiovascular 
responses to forearm ischemia. Clinical Journal o f Pain, 8, 16-25.
55
Malone, M. D. & Strube, M. J. (1988). Meta-analysis of non-medical treatments for 
persistent pain. Pain, 34, 231-244.
McCracken, L. M. (1998). Learning to live with the pain: acceptance of pain predicts 
adjustment in persons with persistent pain. Pain, 74, 21-27.
McCracken, L. M., Carson, J. W., Eccleston, C. & Keefe, F. J. (2004). Acceptance and 
change in the context of persistent pain. Pain, 109, 4-7.
McCracken, L. M. & Gross, R. T. (1998). The role of pain-related anxiety reduction in 
the outcome of multidisciplinary treatment for chronic low back pain: Preliminary 
results. Journal o f Occupational Rehabilitation, 8, 179-189.
McCracken, L. M. & Turk, D. C. (2002). Behavioural and cognitive-behavioural 
treatment for persistent pain: Outcome, predictors of outcome, and treatment process. 
Spine, 27(22), 2564-2573.
McCracken, L. M., Vowles, K. E. & Eccleston, C. (2004). Acceptance of persistent pain: 
component analysis and a revised assessment method. Pain, 107, 159-166.
Mendelson, G. (1992). Compensation and chronic pain. Pain, 48: 121-123.
Millon, T., Green, C. J. & Meagher, R. B. (1982). A new psychodiagnostic tool for 
clients in rehabilitation settings: The Millon Behavioral Health Inventory (MBHI). 
Rehabilitation Psychology, 27(1), 23-35.
Morley, S. (2004). Editorial: Process and change in cognitive behaviour therapy for 
persistent pain. Pain, 109, 205-206.
Morley, S. & Williams, A. (2002). Conducting and evaluating treatment outcome 
studies. Chapter 3, In Turk and Gatchel: Psychological Approaches to Pain Management 
(2nd Ed). Guildford: New York.
Morley, S., Eccleston, C., & Williams, A. (1999). Systematic review and meta-analysis 
of randomized controlled trials of CBT and behaviour therapy for persistent pain in 
adults, excluding headache. Pain, 80, 1-13.
Morley, S., Hussain, S., & Williams, A. (2005). Testing the cognitive mediation model 
of change in a CBT based pain management program. Using a 3-wave panel multiple 
regression model to test for general and specific cognitive predictors. (In preparation)
Nicassio, P. M., Wallston, K. A., Callahan, L. F., Herbert, M., & Pincus, T. (1985). The 
measurement of helplessness in rheumatoid arthritis: The development of the Arthritis 
Helplessness Index. Journal o f Rheumatology, 12, 462-467.
Nicholas, M. K. (1989). Self-efficacy and chronic pain. Paper presented at the annual 
conference of the British Psychological Society. St. Andrews.
56
Osbome, T. L., Raichle, K. A. & Jensen, M. P. (2006). Psychological interventions for 
persistent pain. Physical Medicine and Rehabilitation Clinics o f North America, 17 (2), 
415-433.
Pawlick, K. & Middaugh, S. J. (2002). Persistent pain in the older adult. Chapter 28, In 
Turk and Gatchel: Psychological approaches to pain management (2nd Ed). Guildford: 
New York.
Radojevik, V., Nicassio, P. M. & Weisman, M. H. (1992). Behavioural intervention with 
and without family support for rheumatoid arthritis. Behavior Therapy, 23, 13-30.
Rainville, J., Sobel, J. B., Hartigan, C. & Wright, A. (1997). The effect of compensation 
involvement on the reporting of pain and disability by patients referred for rehabilitation 
of chronic low back pain. Spine, 22, 2016-2024.
Richardson, I. H. & Richardson, P. H. (1999). Does cognitive change predict the 
outcome of cognitive-behavioural pain management? Psychology, Health and Medicine, 
4(1), 27-44.
Rosentiel, A. K., & Keefe, F. J. (1983). The use of coping strategies in chronic low back 
pain patients: Relationship to patient characteristics and current adjustment. Pain, 17, 
33-44.
Roth, T. & Fonagy, P. (2005). What Works for Whom? (2nd Ed). Guildford Press: New 
York.
Smeets, R. J. E. M., Vlaeyen, J. W. S., Kester, A. D. M. & Knottnerus, J. A. (2006). 
Reduction of pain catastrophizing mediates the outcome of both physical and cognitive- 
behavioral treatment in chronic low back pain. The Journal o f Pain, 7 (4), 261-271.
Spinhoven, P., Kuile, M., Kole-Snijders, A. M. J., Mansfeld, M. H., Ouden, D. J. & 
Vlaeyen, J. W. S. (2004). Catastrophizing and internal pain control as mediators of 
outcome in the multidisciplinary treatment of chronic low back pain. European Journal 
o f Pain, 8 (3), 211-219.
Taimela, S., Diederich, C., Hubsch, M. & Heinricy, M. (2000). The role of physical 
exercise and inactivity in pain recurrence and absenteeism from work after active 
outpatient rehabilitation for recurrent or chronic low back pain: a follow-up study. Spine, 
25 (14), 1809-1816.
Tait, R.C., Pollard, C.A., Margolis, R.B., Duckro, P.N. & Krause, S.J. (1987). The Pain 
Disability Index: psychometric and validity data. Archive o f Physical and Medical 
Rehabilitation, 68(7):438-41.
Tollison, C.D. (1993). The comprehensive diagnosis of spinal pain: A new 
psychodiagnostic instrument. Orthopedic Review, 22, 335-340.
57
Tota-Faucette, M. E., Gil, K. M., Williams, D. A., Keefe, F. J. & Goli, V. (1993). 
Predictors of response to pain management treatment: The role of family environment 
and changes in cognitive processes. Clinical Journal o f Pain, 9 (2), 115-123.
Turk, D. C. & Rudy, T. E. (1991). Neglected topics in the treatment of persistent pain 
patients -  relapse, non-compliance, and adherence enhancement. Pain, 44, 5-28.
Turk, D. C., Rudy, T. E., & Sorkin, B. A. (1993). Neglected topics in chronic pain 
treatment outcome studies: Determination of success. Pain, 53, 3-16.
Vaccaro, A. R., Ring, D., Scuderi, G., Cohen, D. S. & Garfin, S. R. (1997). Predictors of 
outcome in patients with chronic back pain in low-grade spondylolisthesis. Spine, 17, 
2030-2035.
Von Korff, M., Ormel, J., Keefe, F. J., & Dworkin, S. F. (1992). Grading the severity of 
chronic pain. Pain, 50, 133-149.
Wall, P. D. (1994). Introduction. (P. 1-7). In: Wall, P. D. and Melzack, R. (Eds), 
Textbook of pain (Third Edition). Edinburgh: Churchill Livingstone.
Ware, J. E., & Sherboume, C. D. (1992). The MOS 36-Item Short-Form Health Survey 
(SF-36®): I. conceptual framework and item selection. Medical Care, 30(6):473-83.
Williams, A. C. DE C. (1993). Inpatient pain management of persistent pain. In: M. 
Hodes and S Moorey (Eds), Psychological treatment in human disease and illness. 
London: Gaskell Press.
Williams, A. C. DE C., Nicholas, M. K., Richardson, P. H., Pither, C. E., Justins, D. M., 
Chamberlain, J. H., Harding, V. R., Ralphs, J. A., Jones, S. C., Dieudonne, I., 
Featherstone, J. D., Hodgson, D. R., Ridout, K. L. & Shannon, E. M. (1993). Evaluation 
of a cognitive behavioural programme for rehabilitating patients with persistent pain. 
British Journal o f General Practice, 43, 513-518.
Williams, A.C.deC., Morley, S., & Black, S. (2002). Grant report: Empirical evaluation 
of best practice in chronic pain management: influence of patient characteristics and 
treatment type on outcome, www.info.doh.gov.uk/doh/refr_web.nsf
Williams, A. & McCracken, L. M. Chapter 13 In: Asmundson, G. J. G., Vlaeyen, J. W. 
S., and Crombez, G. (2004). Understanding and treating pain. Oxford University Press. 
New York: Oxford University Press (pp. 293-312).
Winterowd, C., Beck, A. T., & Gruener, D. (2003). Cognitive therapy with chronic pain 
patients. Springer Publishing Company
European Guidelines on the management of chronic non-specific lower back pain
(2004). www.backpaineurope.org
58
Part 2: Empirical paper
Cognitive-Behavioural Therapy for persistent pain: does adherence 
affect outcome at one-month follow-up?
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Abstract
Patients’ extent of adherence to the use of cognitive techniques and behavioural changes 
learnt during the course of intensive cognitive-behavioural treatment for persistent pain 
have long been assumed to influence maintenance of treatment gains. However, no 
research has investigated the causal influence of adherence on short-term outcome. The 
aims of this paper are to assess determinants of adherence to treatment recommendations 
and to examine the extent to which cognitive and behavioural adherence predicts better 
outcome of cognitive-behavioural treatment for persistent pain. Longitudinal data from 
a sample of 2345 persistent pain patients who attended a multicomponent treatment 
programme were subjected to structural equation modeling in the form of path analyses. 
Adherence emerged as a mediating factor linking post-treatment and follow-up 
treatment outcome, but contributed only 3% of the variance in follow-up outcomes. 
Combined end-of-treatment outcomes and adherence factors accounted for 72% of the 
variance in outcome at one-month follow-up. Assuming that the measures used 
adequately quantify adherence, these findings question the emphasis normally given to 
adherence in the maintenance of behavioural and cognitive change, and their clinical 
implications are discussed.
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1. Introduction
Chronic or persistent pain is defined as continuous, long-term pain that has continued 
beyond three months, or beyond the expected time for healing (Elliott, Smith, Penny, 
Smith & Chambers, 2000). It has widespread destructive consequences often resulting 
in a range of emotional problems, such as depression and pain-related fear (Eccleston, 
2001), and its treatment costs in the NHS are enormous (Maniadakis & Gray, 2000). 
Treatment options for the management of persistent pain range from invasive surgical 
procedures to use of medications such as opioids and other analgesic agents, alternative 
therapies such as needle acupuncture, and psychological therapies.
Many treatment options (e.g. surgical treatment or use of medications) aim to reduce 
patients’ levels of pain. In contrast, when patients are referred to psychological 
treatment it is often for the purpose of learning behavioural and cognitive methods for 
reducing the experience and impact of their pain (McCracken, Carson, Eccleston & 
Keefe, 2004). More specifically, cognitive-behavioural therapy (CBT) aims to enhance 
quality of life and pain-related coping, and to reduce disability and pain-related 
difficulties with functioning. It is therefore a rehabilitative approach and the emphasis is 
placed on improvement in function despite residual pain.
Much evidence, from Cochrane and other systematic reviews (e.g. Morley, Eccleston & 
Williams, 1999), reveals that CBT delivered within a multicomponent treatment 
programme is beneficial and recommended for patients with persistent pain (Koes, van
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Tulder, & Thomas, 2006). However, it has been argued that the success of therapy 
should be measured by its ability both to improve patient functioning at the end of 
treatment and to maintain that improvement after therapy ends (Roth & Fonagy, 2005). 
An important question for all therapists is why some patients who show initial treatment 
success are able to maintain their treatment gains, while other patients are not. In recent 
years researchers have striven to develop their understanding of the long-term effects of 
treatments and to identify both general and specific factors that may influence and 
contribute to the variance in maintenance of treatment gains.
On the basis of learning theory (e.g. Bandura, 1989), one variable that has been 
examined as having an influence on long-term treatment outcomes is a patient’s use of 
the strategies and techniques taught during the treatment programme (adherence), after 
the treatment programme has ended. Unfortunately there is no consensus either on the 
definition or measurement of adherence.
The World Health Organisation (2003) defined treatment adherence as the 
correspondence between a regimen offered by the healthcare provider (e.g. medication 
and changes in lifestyle) and the patient’s behaviour to implement such a plan. In other 
words, it is the degree to which patient behaviours coincide with healthcare providers’ 
recommendations. Self-report is widely used in the study of adherence, not least 
because of its convenience, and the principal techniques used for measuring adherence 
are patient self-report and the judgement of professionals (Turk & Rudy, 1991; Vitolins, 
Rand, Rapp, Ribisl & Sevick, 2000).
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Adherence research is vital within the field of persistent pain since rehabilitative 
programmes for persistent pain aim to help patients adopt methods for both physical and 
psychological self-management of their condition, that is, they aim to get patients to 
make long-term lifestyle changes. Clinicians help to plan, execute, and guide the 
practice of specific changes in behaviours and recommend that patients will continue to 
engage in those behaviours. Clinicians therefore need to know whether adhering to such 
recommendations has an influence on clinical outcome. If treatment adherence does, as 
expected, impact on clinical outcome, it suggests that further research is required to 
identify factors that influence treatment adherence. This question is imperative in the 
field of persistent pain.
Does adherence to treatment recommendations influence clinical outcome?
Much adherence research has focused on adherence to regimens aimed at weight loss, 
smoking cessation, and continued use of long-term medication (e.g. Osterberg & 
Blaschke, 2005; Vermeire, 2001). As expected, findings from these studies show that 
sustained behaviour change is required in order to maintain improvements made during 
treatment. Similar findings have been demonstrated in the general mental health field.
In the field of general mental health, several studies (see Antonuccio, Danton, & 
DeNelsky, 1995) indicate that compared to medications, CBT is associated with fewer 
relapses following treatment and better maintenance of treatment gains. They suggest 
that skill acquisition during treatment and the continued use of these skills in the follow- 
up period may be the cause of this difference. This finding implies that for general
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mental health difficulties, behavioural and cognitive changes learnt during the course of 
treatment need to be sustained in order for treatment gains to be maintained and 
extended (Roth & Fonagy, 2005). Unfortunately, the picture is not as clear in the field 
of persistent pain.
Despite therapists who work with patients with persistent pain recommending that 
patients should continue to use techniques taught during treatment, there have been 
relatively few empirical studies of the therapeutic effects of adherence on follow-up 
outcome following treatment for persistent pain. A review article by Turk and Rudy 
(1991) represents the most comprehensive examination of the role of adherence on 
maintenance of treatment gains in the field.
Turk and Rudy (1991) conducted a review of the available literature on poor adherence 
and relapse in persistent pain, to examine the question of the role of continued practice 
of pain management methods in the maintenance of treatment gains. Their review of 
studies on arthritis (e.g. Basler & Rehfisch, 1991) and on heterogeneous pain clinic 
patients (e.g. Lutz, Silbret & Olshan, 1983) suggested that failure of adherence and 
relapse were related; however, this association was less well established for other 
disorders. They therefore argued that failure to practice or employ coping strategies, 
exercises, relaxation techniques, and other methods taught during treatment in the 
follow-up period contributed to relapse.
A further early study by Nicholas, Wilson & Goyen (1991) also showed that continued 
rates of practice of pain management strategies, even at modest rates, meant that post­
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treatment improvements were maintained at follow-up. They agreed that maintenance of 
treatment gains requires continued use of the skills and behaviours learned in treatment.
The evidence in this area is therefore sparse on the role of adherence in the maintenance 
of treatment gains. The available evidence implies that adherence to treatment 
recommendations may influence follow-up outcomes; although it remains unclear 
whether adherence to treatment regimens is necessary to maintain treatment gains.
Factors influencing treatment adherence
In recent years a number of factors, both psychological and non-psychological, have 
been hypothesised to influence extent of adherence to treatment recommendations. 
However, only a handful of studies were found to have investigated predictors of 
adherence in the field of cognitive and behavioural change in persistent pain.
One factor that has been investigated as having an influence on amount of adherence is 
level of depression. For example, DiMatteo, Lepper & Crogham (2000) found that 
patients with depressive symptoms were at greatest risk of poor adherence to medical 
treatment. More specifically in the persistent pain field, Jensen, Turner and Romano 
(1994) showed that reduced depression scores were associated with the continued use of 
muscle strengthening exercises and cognitive techniques to challenge beliefs about pain. 
Similarly, Fielding and Duff (1999) showed that high levels of psychological distress 
were associated with adherence difficulties. These studies therefore suggest that
65
negative emotional factors, such as depressive symptoms, are associated with poor 
adherence to treatment.
Other psychological characteristics, such as level of self-efficacy, have also been 
examined for their impact upon treatment adherence. For example, Fraser, Hadjimichael 
& Vollmer (2003) conducted a study investigating the influence that levels of self- 
efficacy had on adherence in multiple sclerosis patients. They found that baseline levels 
of self-efficacy predicted adherence to daily self-administered injections. They 
concluded that low levels of self-efficacy negatively influence treatment adherence.
Other factors that have been shown to negatively influence levels of treatment adherence 
after treatment has ended include low expectations for treatment and poor outcomes by 
the end of treatment. Erlen and Caruthers (2007) suggest that for patients with physical 
disabilities low expectations for treatment success may lead to poor adherence to 
treatment recommendations, as the patient may see little point in adhering. Furthermore, 
Taimela, Diederich, Hubsch & Heinricy (2000) indicate that patients with less 
favourable outcome during treatment were less likely to participate in physical exercises 
post-treatment. They therefore conclude that those with good outcome in pain reduction 
during the treatment course were more likely to participate in physical exercise after the 
treatment phase had ended. Erlen and Caruthers (2007) go on to suggest that for 
persistent pain patients, adherence to components of their therapy such as exercise will 
only be sustained given adequate adherence to pain therapy in the first instance. 
Therefore they suggest that adherence predicts adherence.
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A final factor that has been suggested to influence treatment adherence is the complexity 
of the treatment regimen. Erlen and Caruthers (2007) state that only 50% of patients 
with physical disabilities adhere to uncomplicated treatment regimens, such as taking 
one medication, while they believe that this figure is likely to be even less for more 
complex regimens. Berg, Evangelista & Dunbar-Jacob (2002) investigate this 
hypothesis and conclude that treatment adherence is likely to decline when the treatment 
regimen becomes more complex, for example if the regimen is time-consuming or 
involves multiple elements. This suggests that patients are more likely to adhere to a 
single simple recommended regimen, than to a single more complex regimen or multiple 
tasks.
Summary
Attempts to examine the question of how adherence to programme recommendations 
and practice of skills may be related to maintenance of treatment gains have so far used 
very simple models. It seems from the little evidence available that adherence to 
treatment regimens is associated with better clinical outcomes, and that many factors 
may influence rates of adherence. However, it has been shown that there is presently no 
evidence, either in the general mental health or the persistent pain fields, that any 
particular rate of continued practice of strategies is necessary to maintain treatment 
gains. Also, various methodological problems have plagued the measurement of patient 
adherence. Measures of adherence have focused on the self-reported frequency of 
adherence only, and studies have not allowed for adequate consideration of 
measurement error. As a consequence limited results have been produced.
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No attempt has been made to examine or to clarify the nature of the link between 
adherence and the maintenance of treatment gains in the persistent pain field. Therefore 
the causal structure that accounts for any association is not known and the contribution 
that continued practice of pain management strategies post-treatment plays on follow-up 
outcome remains unclear.
The Present Study
The present study attempts to model (using substantive sample sizes and multiple 
measures of adherence) how adherence to treatment methods may predict follow-up 
treatment outcome for persistent pain sufferers.
Research in this area has important theoretical, treatment, prevention, and public policy 
implications. For example, if adherence to treatment is found to predict follow-up 
treatment maintenance then it suggests that appropriate maintenance of change 
components should be included in CBT treatments for persistent pain (Eccleston, 2001). 
Until this issue is resolved, clinicians are unable to provide clear evidence-based 
recommendations to patients at the end of treatment. Acquiring knowledge of the 
impact and of the mechanism through which adherence impacts follow-up outcome will 
be a valuable advance in the field as it will promote long-term behaviour change for 
patients with persistent pain to ensure that gains are maintained and extended after 
regular treatment ends.
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VAims
The primary purpose of this exploratory study was to explore the relationships between 
post-treatment outcomes, adherence to behavioural and cognitive coping strategies, and 
follow-up outcomes, in patients who had completed a multicomponent pain programme. 
Two hypothetical causal models were proposed to explain the relationships between 
post-treatment outcome, adherence, and follow-up outcome. A large data-set, multiple 
outcome measures and multiple measures of adherence were used to generate multi­
indicator latent variables using exploratory factor analysis techniques. The fit of the 
causal models was examined to assess to what extent, if any, adherence contributes to 
the prediction of outcomes at one-month follow-up.
Therefore, the present exploratory study has the following aims:
a.) To investigate the multidimensionality of adherence as a theoretical construct 
using exploratory factor analysis, to identify latent factors of adherence from 
multiple indicators;
b.) To compare several possible causal models which relate adherence to 
outcome at follow-up using Structural Equation Modeling (SEM).
Hypothesised causal models
There are two hypothesised causal models: adherence as a mediator of outcomes at 
follow-up; and adherence as an independent predictor of outcomes.
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1.) Adherence as a mediator 
A “mediator’ is defined as ‘the generative mechanism through which the focal 
independent variable is able to influence the dependent variable of interest’ (Baron & 
Kenny, 1986). In outcome research, mediators of change are those characteristics of the 
individual that are changed by the treatment and that, in turn, produce change in the 
outcome of interest (Whisman, 1993). Therefore, the logic involved in hypothesising 
mediating relationships is that “the independent variable influences the mediator, which 
in turn influences the outcome” (Holmbeck, 1997, p. 600).
It may be that adherence to treatment mediates or partially mediates the relationship 
between psychological state (contentment) post-treatment and psychological state at 
follow-up. This hypothesis is based on the premise that level of functioning and 
contentment at the end of treatment (post-treatment) may influence the extent to which a 
programme graduate adheres to treatment recommendations, which in turn will influence 
psychological state at follow-up. This hypothesis would suggest that patients who are 
severely depressed or who have low self-efficacy at the end of treatment may, through 
low motivation, adhere poorly to the recommended techniques, and will therefore show 
poorer maintenance of treatment gains at follow-up.
This model would predict the following:
a.) that psychological state post-treatment predicts levels of adherence, with 
higher levels of contentment being associated with higher levels of 
adherence;
b.) that adherence to treatment recommendations predicts maintenance of gains 
in psychological state at follow-up, with higher levels of adherence 
predicting higher levels of wellbeing at follow-up;
c.) that the strength of the relationship between post-treatment psychological 
state and psychological state at follow-up will be greater when adherence is 
greater.
2.) Adherence as an independent predictor 
This model suggests that level of adherence influences follow-up outcomes; but that 
adherence level is not predicted by a patient’s level of functioning at the end of 
treatment (i.e. adherence does not mediate the change). In this model, adherence may be 
predicted by some other variables, for example by psychological variables such as 
motivation or social support, or by personal/medical variables such as age, gender, or 
site of pain.
2 Methods
Sample/data
Data were extracted from a database on 3498 persistent pain patients entering a 
multicomponent pain management programme between 1989 and 2004. Some patients 
in the present study have been included in several prior repoits, but the focus and 
methods of these were different (e.g. Morley, Hussein & Williams, in preparation;
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Williams, Morley & Black, 2002). Personal and medical, clinical and psychological 
data were routinely collected from patients using standardised assessments.
Patients had been referred from all over the UK and attended a two or four week (9-day 
or 16-day) inpatient pain management programme. The treatment aimed to restore 
optimal physical function, range and level of activity, improve mood, and to reduce the 
use of drugs and other health care. The programme also provided participants with a 
more helpful understanding of and beliefs about pain and its implications. It aimed to 
teach people habit change for life. To meet these aims, the treatment programme 
included exercise and stretching routines, goal setting, pacing of activities, education 
sessions, cognitive and behavioural sessions, drug reduction, relaxation, sleep 
management, relapse prevention and family involvement (where appropriate).
As adherence was the variable of interest in the present study, it was decided that all 
cases without adherence data at one-month follow-up would be deleted, to reduce 
missing data. Although such a strategy meant that it was likely that many cases with 
low adherence and lower outcome scores at the end of treatment were omitted, a 
criterion for selection was that they had attended their one-month follow-up appointment 
and that reports of their levels of adherence at that time were available. A sample of 
2435 remained and was used in the analysis.
Randomly splitting the above sample in two (using the SPSS select random cases 
function) produced two sample groups, which were treated as the exploratory group (n = 
1204) and the validation group (n = 1231). The personal and medical characteristics of
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the groups are listed in Table 1. No significant differences were found between the two 
samples on any of these variables, except gender: the exploratory group had significantly 
more females in its sample than the validation group (x2 (1) =8.86, p=0.003).
Table 1: Participant Demographics
Variable
Participants
Exploratory
Group
(n=1204)
Validation
Group
(n=l 231)
Test o f mean 
differences
X2/t-value (df) P
Dem ographics
Gender (9c female) 59 65 8.86(1) 0.003
Mean age (years) 45 45 0.24(1112) 0.807
Ethnicity-white (9c) 88 89 0.84(3) 0.839
Further education (>16years) (9c) 48 48 0.24(2) 0.885
Mean months since work 62 60 1.47(901) 0.142
Mean months of pain 103 109 -1.46(1088) 0.144
Main Site o f  Pain 
Low back ( c/c) 49 49 9.75(9) 0.371
Shoulder/arm/hand (9c) 11 11 - -
Hip/leg/feet (9c) 10 9 - -
Multiple sites (9c) 16 15 - -
Other (9c)
(e.g. head/neck/chest/abdomen/pelvis) 14 16 - -
Employment Status 
Unemployed due to pain (9c) 28 27 3.87(7) 0.795
Employed (9c) 20 21 - -
Permanent sick/disabled (9c) 34 36 - -
Retired (9c) 11 10 - -
Other (9c)
(student/homemaker/unemployed for other reasons) 7 6 _
Living Situation  
Living alone (9f) 17 20 4.95(5) 0.422
Living w ith partner, or partner and children (9c) 66 65 - -
Other (9c)
(living with children only/friends/other relatives) 17 15
Key: n = number of participants; x2/t-value (df) = Chi-square/t-value and degrees of freedom; p = 
probability value.
Ethics
Ethical approval was granted by St Thomas’ Hospital Research Ethics Committee (See 
Appendix 1) and research and development approval was obtained from The Guy’s and
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St Thomas’ NHS Foundation Trust Research and Development Department. These were 
granted as an amendment and an extension on approval previously obtained for research 
using the data sample. To ensure confidentiality, data were supplied anonymised.
Measures
The following measures were selected from a wider range of measures used routinely as 
part of the assessment of patients undergoing treatment at the pain unit. The selected 
measures were chosen for their ability to represent the constructs of interest in this study. 
Measures were administered at pre-treatment assessment (up to two weeks before 
starting treatment) (Time 1), post-treatment at discharge on the last day of treatment 
(Time 2), and at one-month follow-up (Time 3), unless otherwise specified. Some 
measures were also collected at 6-month, 9-month, and 12-month follow-up, although 
due to the extent of missing data these were not utilised in the current study.
Outcome Measures
Beck Depression Inventory (BDI; Beck, Ward, Mendelson, Mock & Erbaugh, 1961) 
was used as an index of depressive thinking and affect. The BDI consists of 21 groups 
of items, each focusing on a specific manifestation of depression (sadness, 
dissatisfaction, suicidal ideation etc). Item scores range from 0 to 3, giving a total score 
from 0 to 63 with higher scores indicating higher depression. The validity of the BDI 
for the measurement of depressive symptoms in persistent pain has however been 
questioned by Morley, Williams & Black (2002). They held that the BDI used with
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chronic pain patients can lead to inflated depression scores, because it includes somatic 
items that have a different meaning for chronic pain patients compared to depressed 
patients. Factor analysis (exploratory and confirmatory) identified a factor of ‘self 
denigration’ which they suggested could better indicate depressive thinking in persistent 
pain patients. This factor consisted of items C (sense of failure), E (guilt), F 
(punishment), G (self-dislike/ disappointment), H (self-blame), and N (body image 
change/ unattractiveness). In this study the BDI ‘self denigration’ factor scores (BDI-f) 
were included in the analyses as the measure of depression/mood. Scores ranged from 0 
(indicating no symptoms/ positive view of self) to 18 (indicating a very negative view of 
self): however, for the purposes of this study these scores were reversed so that 0 = very 
negative view of self and 18 = positive view of self. This was done so that 
improvements on this measure were indicated on the scale in the same direction as 
improvements on other measures.
Pain Self-Efficacy Questionnaire (PSEQ; Nicholas, 2007). This self-report 
questionnaire was used to assess the degree of confidence that patients have in achieving 
activities in ten different areas despite their pain. Each statement (e.g. I can enjoy 
things, despite the pain) is followed by a seven-point scale ranging from 0 (not at all 
confident) to 6 (completely confident). Total scores range from 0 (no confidence at all) 
to 60 (completely confident for all activities). This measure has been shown to have 
good test-retest reliability and internal consistency (e.g. Cronbach's a was calculated at 
0.92) (Asghari and Nicholas, 2001).
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Pain Catastrophising Scale (PCS; Sullivan, Bishop & Pivik, 1995). This is a brief self­
completion measure of catastrophising. It samples the tendency to attend to pain stimuli, 
to overestimate their threat value and to underestimate the ability to handle that threat.
13 statements are rated on a five-point scale ranging from 0 (not at all) to 4 (all the 
time), and total scores range from 0 to 52. It is a robust measure for the assessment of 
the cognitive construct of catastrophising and no other measure has proved as heuristic 
or explanatory. Internal consistency is satisfactory for the PCS total (Cronbach’s 
a = 0.91) and the test-retest reliability is satisfactory for the whole scale (ICC = 0.82) 
(Chatzidimitriou, Georgoudis, Manousou, Argira, Vadalouka, Anastasopoulou, 
Pavlopoulos & Siafaka, 2006). It was developed from the catastrophising subscale of 
the CSQ (see below: Sullivan et al., 1995). This measure was introduced as the measure 
of catastrophising within the pain management unit in 2000, and was taken only at Time 
3 due to questionnaire burden on patients.
Coping Strategies Questionnaire (CSQ; Rosenstiel & Keefe, 1983). The 
catastrophising subscale of the CSQ was originally used within the service as a measure 
of level of catastrophising. The sub-scale includes six self-referent items such as ‘I feel 
I can’t stand it anymore’. Patients indicate on a scale of 0 (never) to 6 (always) the 
frequency of occurrence of making self-statements resembling each item. The total 
scores for the catastrophising subscale range from 0 to 36 and it has been shown to be a 
robust factor. This measure was again only taken at Time 3, and was replaced by the 
PCS as the measure of catastrophising in 2000.
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As a consequence of the change in the measure of catastrophising participants in the 
sample were either administered the CSQ or the PCS. During data manipulation, scores 
on the catastrophising subscale of the CSQ were re-coded to a scale of 0-52 by 
multiplying scores by 51/36. A single scale of catastrophising was therefore available 
for all participants during data analyses. In the original scale 0 = no catastrophising and 
52 = high levels of catastrophising, but this scale was reversed for the purposes of the 
study so that 0 = high levels of catastrophising and 52 = no catastrophising.
The combining of scores from the PCS and CSQ was justified on the basis that the PCS 
was developed with the CSQ authors’ involvement, and because the PCS included all six 
items from the CSQ. In addition, research has demonstrated a high correlation between 
PCS and CSQ scores (r = 0.89) (Chatzidimitriou et al. 2006).
Adherence Measures
All measures of adherence were completed at Time 3 only.
Exercise Frequency -  patients reported how often they currently carried out their 
circuit-exercises. These were general fitness and strength exercises such as sit-ups, 
which aimed to build strength and flexibility. Each patient reported adherence using one 
of six categories, where 1 indicated they have stopped doing the exercises completely 
and 6 indicated they do them at least once a day.
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Stretch Frequency - patients reported how often they currently carried out their 
stretching (general gentle stretches to extend tendons and muscles) by ticking one of six 
categories, where 1 indicated they have stopped completely and 6 indicated they do 
them at least once a day.
Pacing Frequency - patients reported how often they were using activity pacing 
(breaking activities down into small manageable steps and building up activity slowly) 
by ticking one of six categories, where 1 indicates they had stopped completely and 6 
indicates they were doing it at least once a day.
Pacing Occasion - patients reported the occasions on which they used the pacing by 
ticking one or more of six categories, where l=not at all, 2=when I remember, 3=when 
the pain is bad, 4=for some activities, 5=indoors only and 6=as a daily approach. These 
categories were derived from patient reports during the programme and at follow-up. 
These were re-coded as follows: l=not at all, 2=when the pain is bad, 3= when I 
remember, when indoors, or for some activities and 4=as a daily approach. This 
represents a hierarchy, derived from consultation with two experts in the field of 
persistent pain, such that 1 indicates the poorest level of adherence and 4 indicates the 
best level.
Cognitive Techniques Frequency - patients reported how often they were using the 
methods taught for challenging unhelpful thoughts (e.g. identifying thought biases and 
looking for evidence) by ticking one of six categories, where 1 indicates that they had 
stopped completely and 6 indicates they were doing them at least once a day.
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Cognitive Techniques Occasion - patients reported the occasions when they were using 
the cognitive techniques, where l=not at all, 2=when I remember, 3=when the pain is 
bad, 4=when I’m anxious, 5=when I’m depressed, 6=when someone upsets me and 7=as 
a daily approach. Again following discussion with two experts in the field, items on this 
scale were recoded to produce a hierarchy, where 1 indicated the poorest level of 
adherence and 4 indicated the best level of adherence. The re-coded scale was as 
follows: l=not at all, 2=when the pain is bad or when I remember, 3= when I’m 
depressed, when I’m anxious, or if someone upsets me, and 4= as a daily approach.
Data Analysis
SPSS (Window's version 11.0) and AMOS (Version 5.0; Arbuckle & Wothke, 1999) 
software packages were used during data analysis.
Missing Data Techniques
Table 2 illustrates the percentages of missing data for each measure within each data 
sample, and more specifically. Table 3 shows the number of responses within each 
category for each adherence variable.
Large amounts of missing data are problematic within research studies as it makes the 
sample used unrepresentative, and, if the data are not missing through random processes 
but through some systematic effect, it also threatens internal validity. Table 2 reveals
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that the amounts of missing data range from 0% to 4.1%, with the highest percentage 
being for Mood at Time 3 for the exploratory sample. This can be considered to be well 
within acceptable limits (Field, 2005). Reasons for missing patient data include (a) 
measure was not administered to the patient; (b) data entry clerk did not input the data; 
and (c) patient did not attend the appointment. Sorting of the data by treatment group 
(patients attended their inpatient treatment in small groups, which were numbered) 
revealed that data were mainly missing for whole groups of patients at each time point, 
indicating that the main reason for missing data was due to reason (b), that is, due to 
difficulties with staff-related data collection and entry rather than due to patient attrition. 
This conclusion was confirmed through consultation with a member of staff at the pain 
management unit, who revealed that pockets of data that were gathered from patients 
were not entered onto the database by the data entry clerk. Therefore it appears that data 
were missing at random.
Table 2: Missing Data Percentages for each Variable
Variable
Exploratory Sample 
(n=1204)
(% data missing)
Validation Sample 
(n=1231)
(% data missing)
M easures (time 1)
Mood 0.0% 0.0%
Self efficacy 2.4% 2.8%
M easures (time 2)
Mood 0.0% 0.0%
Self efficacy 2.3% 2.9%
M easures (time 3)
Mood 4.1 % 3.5%
Self efficacy 1.5% 2.1%
Non-catastrophic thinking 0.0% 0.0%
Occ. of pacing 0.0% 0.0%
Occ. of challenging thoughts 0.2% 0.2%
Frq. o f stretching 0 . 1 % 0 . 1 %
Frq. o f exercise 0.3% 0.5%
Frq. o f pacing 0.7% 1.6%
Frq. o f challenging thoughts 1.3% 1.0%
Key: Frq. =frequency; Occ. =occasion; n = number of participants
80
During analyses performed using SPSS, listwise deletion was the approach used to 
handle missing data. In this method, cases are deleted from the sample if they have 
missing data on any of the variables in the analysis to be conducted, producing a 
w orking sample with no missing data but a reduced sample size.
In contrast, AMOS uses a full information maximum likelihood (FIML) method 
(Arbuckle, 1999), otherwise known as direct maximum likelihood, for dealing with 
missing data. This means that the software recognises missing data and uses all 
observed data values to estimate models. This method assumes that the data have 
multivariate normal distribution and that the missing data mechanism can be 
disregarded, i.e., that the data are missing at random (Allison, 2003). FIML is the 
recommended estimation method of choice when the data are missing at random 
(Arbuckle & Wothk, 1999).
Table 3 illustrates that for all measures of adherence, across both the exploratory and 
validation sample groups, the majority of participants reported currently using the 
techniques on a daily basis. Very few participants reported having stopped using the 
techniques completely. This implies that most participants were adhering to treatment 
recommendations to a greater or lesser degree at one-month follow-up.
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Table 3
Frequency and percentage o f responses in each category fo r  adherence variables
Exploratory G roup V alidation G roup
Variable Categories (n=1204) (n=1231)
N % N %
Occasion o f  pacing
Not at all 62 5.1 54 4.4
When the pain is bad 65 5.4 64 5.2
When 1 remember, when indoors, or for some activities 456 37.9 436 35.4
As a daily approach 621 51.6 677 55
Missing data 0 0 0 0
Occasion o f  challenging thoughts
Not at all 137 11.4 145 11.8
When the pain is bad or when 1 remember 249 20.7 244 19.8
W'hen I'm depressed, anxious, or if someone upsets me 369 30.6 421 34.2
As a daily approach 447 37.1 419 34
Missing data 2 0.2 2 0.2
Frequency o f  stretching
Stopped 47 3.9 34 2.8
< once a w eek 34 2.8 32 2.6
1 -2 per w eek 82 6.8 76 6.2
3-4 per week 155 12.9 162 13.2
5-6 per week 191 15.9 196 15.9
At least once a day 694 57.6 730 59.3
Missing data 1 0.1 1 0.1
Frequency o f  exercise
Stopped 78 6.5 59 4.8
< once a week 51 4.2 47 3.8
1 -2 per week 116 9.6 118 9.6
3-4 per w eek 232 19.3 264 21.4
5-6 per w eek 210 17.4 219 17.8
At least once a day 513 42.6 518 42.1
Missing data 4 0.3 6 0.5
Frequency o f  pacing
Stopped 65 5.4 61 5
< once a week 42 3.5 34 2.8
1 -2 per week 109 9.1 117 9.5
3-4 per week 187 15.5 166 13.5
5-6 per week 237 19.7 249 20.2
At least once a day 555 46.1 584 47.4
Missing data 9 0.7 20 1.6
Frequency o f  challenging thoughts
Stopped 113 9.4 129 10.5
< once a week 102 8.5 97 7.9
1 -2 per week 223 18.5 236 19.2
3-4 per w eek 188 15.6 191 15.5
5-6 per week 219 18.2 243 19.7
At least once a day 343 28.5 323 26.2
Missing data 16 1.3 12 1
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Data Analysis Stages
The sequence of procedures carried out to arrive at my final model is as follows:
Data Cleaning
Data were coded, univariate outliers were removed and data checked so that variables 
likely to load together on a factor were scored in the same direction. Data were also 
checked for univariate normality and were not found to be problematic. Eyeballing of 
histograms with normal curves for each variable indicated no difficulties with normality. 
Also, skewness and kurtosis values indicate that data did not depart from normality; 
univariate skewness values range from -0.72 to 1.23, with a mean univariate skewness of 
-0.37, and univariate kurtosis values range from -1.25 to 0.59, with a mean value of - 
0.20. Tests for normality, such as Kolmogorov-Smimov, were not used since they are 
overpowered for large sample sizes.
Exploration
The exploratory sample (n = 1204) was used initially to explore which variables loaded 
on which factors and to investigate the pathways from post-treatment outcome to 
outcome at one-month follow-up.
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Determining Latent Variable Structure
An exploratory factor analysis (EFA) was conducted in order to determine the factor 
structure of the construct of adherence. The aim was to account for as much variance as 
possible, while keeping the number of factors extracted as small as possible.
After relevant measured variables had been entered, the following procedure was used to 
conduct and interpret each EFA, as suggested by Dancy and Reidy (2004). Initially a 
matrix of correlation coefficients was produced and a set of factors was extracted.
Matrix algebra was used to reveal correlations of variables with factors (the unrotated 
matrix). This matrix was then rotated (Varimax rotation) to produce a matrix that 
contained the factor loadings (correlations of variables with factors). In addition, 
eigenvalues representing the proportion of variance accounted for by each factor and a 
scree plot (a graph indicating the number of factors plotted against variance accounted 
for) were produced. These were used in the interpretation of the output to decide how 
many factors to keep.
A number of statistical criteria were used in combination with researcher judgement to 
decide how many factors to retain. In keeping with convention, any factor with an 
eigenvalue greater than 1.00 was kept, and values just below 1.00 were inspected for 
possible retention. Also, the scree plots were viewed to see where the slope became a 
plateau, and the amount of variance accounted for by each factor was considered. The 
aim was to explain as much variance with the least number of factors, and to account for 
approximately 75% of the variance.
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Finally, the factors were named using shared characteristics among the constituent 
variables. A minimum factor loading of approximately 0.4 to 0.5 was chosen as a 
criterion on which to base a decision about whether an item should be included in the 
naming process and interpretation of factors, although this figure is arbitrary (Dancy & 
Reidy, 2004). The names of the latent variables in this investigation are based on the 
items that operationalise them, as determined by researcher judgement.
Test o f the Measurement Model
Structural Equation Modeling (SEM) is a collection of multivariate statistical techniques 
that allow a set of hypothesised relationships between independent variables and 
dependent variables to be examined. The same standard assumptions of the general 
linear model hold: normality, homogeneity of error variance, and independence of 
errors.
Using SEM, Confirmatory Factor Analysis (CFA) was initially used to develop a 
measurement model that demonstrated an acceptable fit to the data, to ensure that 
measurement of each latent variable (i.e. the unobserved factors determined from the 
EFA) was psychometrically sound, that is, that it tested the validity of the indicator 
variables (i.e. the observed/measured variables). Therefore, the measurement portion of 
the model reflects the degree to which the indicators represent a latent construct (i.e. 
factor loadings). CFA tests whether the indicator variables relate only to the latent 
variables they purport to represent and whether error terms only relate to each other in
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the ways that have been anticipated. In the measurement model every latent variable 
was allowed to correlate with every other latent variable. The measurement model was 
identified by constraining one unstandardised factor loading for each factor and for all 
the error terms to 1.0. This was necessary to set the measurement scale and to ensure 
that the errors had the same scale of measurement as the variables. The measurement 
model provided the full model against which the more parsimonious structural models 
were later compared.
Test o f the Structural Model
The measurement model was modified so that it represented the alternative theoretical 
models proposed (the structural models). The structural portion of the model reflects the 
interrelationships between constructs (e.g. parameter estimates). Linear equations are 
represented with arrows from the independent to the dependent variables. Path analysis 
was used to explore the hypothesis that adherence mediates the relationship between 
post-treatment psychological state and psychological state at one-month follow-up. 
Therefore the fit of the whole model (measurement and structural) was assessed.
Criteria for Mediation
Baron and Kenny (1986) describe a three step process for determining mediation.
Firstly, the proposed mediators are regressed on the predictor. Secondly, the criterion is 
regressed on the predictor. Finally, the criterion is regressed on both the predictor and 
the mediators. These steps are illustrated using path diagrams in Figure 1. Mediation
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would be implied in the present study if a.) adherence factors are found to be 
significantly correlated to psychological state post-treatment, b.) psychological state at 
one-month follow-up is significantly related to psychological state post-treatment, and
c.) the relationship between psychological state post-treatment and psychological state at 
one-month follow-up decreases (or goes to zero) when adherence factors are entered into 
the equation. Similarly, Holmbeck (1997) stated that a pre-condition for examining 
mediated relationships is that the independent variable is significantly associated with 
the dependent variable prior to testing any model for mediating variables. He stated that 
the extent to which the introduction of the hypothesised mediating variables reduces the 
magnitude of any direct influence is of importance.
Estimation and Model Fit
Maximum likelihood estimation (MLE) methods were used to estimate all model 
parameters simultaneously; this is the most commonly used algorithm in model fitting 
programmes (Kline, 1998). As opposed to ordinary least squares estimation (which 
seeks to minimise the sum of squared distances of the data points to the regression line), 
MLE seeks to maximise the log likelihood (the odds) that the observed values of the 
dependent may be predicted from the observed values of the independents. MLE is an 
iterative process and is appropriate for use with a large sample size and when data are 
normally distributed and continuous (Hox & Bechger, 1998). Goodness-of-fit indices 
were chosen from the array provided by AMOS after consideration regarding critical 
factors such as the large sample size, the complexity of the model, and the estimation
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procedure. The chi-square test of fit (CMIN) (x2), the goodness-of-fit index (GFI), the 
comparative fit index (CFI; Bentler, 1990), the Tucker-Lewis index (TLI; Bentler & 
Bonett, 1980), and the root-mean square error of approximation (RMSEA; Browne & 
Cudeck, 1993) with a 90% confidence limit were used. Chi-square difference tests were 
used to compare nested models. Critical ratios (CRs) were examined to evaluate the 
significance of model parameters. The statistics used to evaluate the models are shown 
in Table 4.
Figure 1 -  Path diagrams illustrating Baron and Kenny’s (1986) steps for determining 
mediation
Step 1 -
M ediator
Predictor
Step 2 -
Criterion
Predictor
Step 3 -
M ediator
C riterion
Predictor
Key: Circles represent latent (unobserved) variables; E = Residual (error in the prediction of endogenous 
variables)
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Table 4: Statistics used to evaluate model fit
Index Type Description of measures of fit/ratios
Good
fit/significance 
indicated by
X2 (CMIN) Likelihood ratio test R epresents the discrepancy between the unrestricted sample covariance 
matrix (saturated model) and the restricted covariance matrix 
(hypothesised model)
Not significant 
value
CR Comparative index Critical ratio is an estimate of each path coefficient divided by its standard 
error and is used to evaluate the significance of model param eters
>1.96 are 
significant at 0.05 
level
GFI Comparative index
Goodness of fit index (Joreskog & Sorbom, 1989) m easures the relative 
amount of variance and covariance in the sample covariance matrix
>0.90
CFI Comparative index Comparative fit index (Bentler, 1990) com pares the hypothesised model to 
the independence model, giving a m easure of complete covariation in the 
data
>0.90 (Bentler, 
1992)
TLI Comparative index Tucker-Lewis index (Bentler & Bonett, 1980) coefficient com pares the fit of 
the model to the independence model
>0.95
RMSEA Root mean square of approximation (Browne & Cudeck, 1993), m easures 
discrepancy per degree of freedom
<0.05 (Browne & 
Cudeck, 1993)
Hoelter's Hoelter's critical N is the largest sample size at which the researcher could 
accept the model at the .05 and .01 levels
>200
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Validation and Sensitivity Testing
The validation sample (n = 1231) was used to cross-validate the final structural model. 
The sensitivity of the final model was also investigated. Sensitivity testing has been 
recommended as a second stage in model evaluation (Learner, 1985), to investigate 
whether the inclusion or exclusion of other variables in the model may have biased 
parameter estimates (missing variable bias). For instance, the exclusion of important 
variables could have inflated the estimate of the effect of adherence on psychological 
state.
3 Results
Descriptives and Correlational Analyses
Table 5 shows the descriptive statistics for all outcome and adherence variables. 
Intercorrelations between these variables are shown in Table 6. 67 of 78 correlations 
can be seen to reach significance at p<0.05. This level of significance was chosen as it 
is the most common level of significance reported in research (Dancy & Reidy, 2004). 
It means that results are considered significant if they would occur by chance 5% of the 
time or less.
Table 6 shows the correlations between outcome and adherence measures. Pre­
treatment outcome measures, mood at time 1 and self-efficacy at time 1, were each 
shown to be related to outcome measures post-treatment (at time 2) and at one-month
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follow-up (at time 3). Also, each post-treatment outcome variable (at time 2) was shown 
to be significantly associated with outcome at one-month follow-up (at time 3). This 
implies that psychological state pre-treatment has an impact on psychological state post­
treatment, which in turn is associated with psychological state at one-month follow-up.
The relevant correlations between outcome measures and adherence variables are also 
shown in Table 6. Two findings are of particular interest here: a.) that pre-treatment 
variables did not appear to be related to adherence; and b.) that post-treatment and one- 
month follow-up outcome variables each showed a strong relationship with adherence.
a.) Pre-treatment scores on outcome measures were not consistently related to 
measures of adherence. Mood at time 1 was not significantly associated with 
any of the adherence variables, except frequency of stretching (r=0.11, 
n=1203, p<0.01) and frequency of pacing (r=0.08, n=1195, p<0.01). Also, 
the only measure of adherence significantly related to self-efficacy at time 1 
was frequency of stretching (r=0.09, n=l 174, p<0.01). This indicated that 
psychological state pre-treatment shared little variance with participants’ 
extent of adherence after treatment has ended.
b.) Mood and self-efficacy post-treatment were however significantly related to 
all measures of adherence, except frequency of challenging thoughts. Also, 
there were significant correlations between mood and self-efficacy at one- 
month follow-up and all adherence measures. This implies that participants 
are more likely to adhere if they had higher post-treatment scores, and that
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they were more likely to do better at follow-up if they have adhered. 
Alternatively, these results could imply that participants are more likely to 
report higher levels of adherence if they were doing well at follow-up.
Finally, Table 6 shows that all adherence variables were positively correlated with one 
another. This indicates that an individual who adheres to one technique is likely to 
adhere to the others.
Differences in the mean scores of outcome variables over time were investigated using 
repeated measures ANOVAs, to reveal whether significant improvements in outcome 
were shown between pre-treatment, post-treatment, and one-month follow-up.
Therefore, analyses were performed to compare levels of mood and self-efficacy over 
the three time points. Analyses revealed significant differences in levels of mood 
(F(2,l 153) = 0.244, p<0.001) and levels of self-efficacy (F(2,l 134) = 0.422, p<0.001) 
between these time points. On average, pre-treatment levels of mood were lower 
(M=13.98, SD=3.43) than at post-treatment (M=15.70, SD=2.76). Similarly, pre­
treatment mean levels of self-efficacy were lower (M=24.48, SD= 12.04) than at post­
treatment (M=34.55, SD= 12.97). Pre-treatment levels of mood and self-efficacy were 
also shown to be lower than at one-month follow-up, M=15.50, SD=3.02, and M=33.06, 
SD= 13.57 respectively. These results imply that improvements in mood and self- 
efficacy had taken place by the end of treatment, and that these improvements were 
maintained at one-month follow-up.
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Table 5: Descriptive Statistics for  Outcome and Adherence Variables
Variable
Participants
Exploratory Group (n=1204)
Mean SD
N (% data 
missing)
Validation Group (n=1231)
Mean SD
N (% data 
missing)
Measures (time 1)
Mood 13.98 3.43 1204(0) 14.14 3.44 1231 (0 )
Self efficacy 24.48 12.04 1175 (2.4) 24.25 11.88 1196 (2.8)
Measures (time 2)
Mood 15.70 2.76 1204 (0) 15.89 2.61 1231(0)
Self efficacy 34.55 12.97 1176(2.3) 34.38 12.94 1195 (2.9)
Measures (time 3)
Mood 15.50 3.02 1155 (4.1) 15.59 2 .8 6 1188(3.5)
Self efficacy 33.06 13.57 1186(1.5) 33.10 13.67 1205 (2.1)
Non-catastrophic thinking 35.80 12.86 1204(0) 36.02 12.66 1231 (0 )
Occasion of pacing 3.36 0.81 1204(0) 3.41 0.78 1231(0)
Occasion of challenging
thoughts 2.94 1.02 1202  (0 .2 ) 2.91 1.00 1229 (0.2)
Frequency of stretching 4.07 1.36 1203 (0.1) 4.15 1.28 1230(0.1)
Frequency of exercise 3.65 1.52 1200 (0.3) 3.71 1.43 1225 (0.5)
Frequency of pacing 3.80 1.46 1195 (0.7) 3.87 1.43 1211 ( 1.6 )
Frequency of challenging
thoughts 3.12 1.65 1188(1.3) 3.06 1.65 1219 (1.0)
Key: N/n = number of participants; SD = standard deviation
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Table 6
Intercorrelations Between All Variables
1 2 3 4 5 6 7 8 9 10 11 12 13
Outcome Variables
1. Mood (time 1) 1
2. Self efficacy (time 1) .370** 1
3. Mood (time 2) .506** .267** 1
4. Self efficacy (time 2) .232** .390** 1
5. Mood (time 3) .553** .255** .625** 346** 1
6 . Self efficacy (time 3) .258** .538** .340** .735** .452** 1
7. Non-catastrophic thinking (time 3) .317** .292** .337** .460** .480** 5 4 7 ** 1
Adherence variables
8 . Occ. o f pacing (time 3) .055 .036 .085** .160** .135** 2 0 3 ** .151** 1
9. Occ. o f challenging thoughts (time 3) .028 .036 .065* 1 io** .105** .2 0 2 ** .145** .338** 1
10. Frq. of stretching (time 3) .107** .094** .108** 196** .148** .264** .155** .347** .246** 1
11. Frq. o f exercise (time 3) .048 .039 .067* .151** 12 2** .242** 148** .361** 2 2 7 ** .661 ** 1
12. Frq. o f pacing (time 3) .083** .004 .088** .131** 125** .180** .163** .682** 329** .407** .422**
13. Frq. o f challenging thoughts (time 3) .019 .0 1 0 .010 .055 .064* .161** .096** .286** 7 3 4 ** .260** 2 5 4 ** .3 7 7 ** i
(*p<.05. **p<.01. All tests were two-tailed). 
Key: Occ = occasion; Frq = Frequency
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Exploratory Factor Analysis
Adherence scores were submitted to principal components factor analysis (Varimax 
rotation). Three orthogonal factors were extracted and a summary of the output is 
shown in Table 7. The rotated solution accounted for all 6 capacities (extraction 
communalities ranged from 0.83 to 0.87), explained 85% of rating variance, and yielded 
two factors with eigenvalues over 1.0. The first factor, termed Cognitive Adherence 
(eigenvalue = 2.98) accounted for 50% of the variance and included two capacities: 
occasion of challenging thoughts and frequency of challenging thoughts. A second 
factor, Physical Adherence (eigenvalue = 1.23), accounted for 21% of the variance and 
included two capacities: frequency of stretching and frequency of exercise. A third 
factor, Pacing Adherence (eigenvalue = 0.87) was also extracted. Although this factor 
did not yield an eigenvalue greater than 1.0, it accounted for 15% of the variance and 
included two capacities: occasion of pacing and frequency of pacing. The clarity of the 
loadings and the absence of substantial cross-loadings indicated that this solution was 
clean. The solution showed that the six adherence measures loaded onto three factors, 
and these were used throughout the remainder of the analyses as latent variables of 
adherence.
Post-treatment and one-month follow-up outcome variables were each combined into a 
single latent variable called ‘psychological state’, with two and three observed variables 
respectively. This decision was based on the premise that it made theoretical sense to 
combine these variables, and because the significant correlations in Table 6 corroborated 
this.
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Table 7: Factor Loadings, Communalities, Eigenvalues, and Percentage o f  Variance fo r  each adherence factor
Item
Factor 1: 
Cognitive 
Adherence
Factor 2:
Physical
Adherence
Factor 3:
Pacing
Adherence Communalities
Occ. o f challenging thoughts 0.91 0.10 0.18 0.87
Frq. o f challenging thoughts 0.91 0.14 0.16 0.87
Frq. of stretching 0.13 0.88 0.19 0.83
Frq. o f exercise 0.10 0.88 0.22 0.83
Occ. of pacing 0.15 0.17 0.90 0.86
Frq. of pacing 0.21 0.26 0.85 0.83
Eigenvalue 2.98 1.23 0.87
Percent of Variance 49.64 20.50 14.54 Total Variance = 84.68
Key: Occ = Occasion; Frq = Frequency
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Model Estimation
Structural equation modeling was used to investigate the relationships among 
psychological state post-treatment, adherence factors and psychological state at 
follow-up. A two-stage SEM approach was adopted in order to first test the quality 
of the measurement items before proceeding to the estimation of the structural model 
(Hulland, Chow, & Lam, 1996). Based on the findings from the EFA and 
correlations, latent variables were constructed, with indicators, and a Measurement 
Model A was specified. Table 8 shows the chi-squared values and goodness of fit 
indices for each model tested.
Measurement Model
The hypothesised Measurement Model A (MMA) illustrating the hypothesised links 
between psychological state post-treatment, psychological state at 1-month follow- 
up, and adherence, is presented in Figure 2. In this model, circles represent 
unobserved variables (factors and error terms), while observed variables (scale 
scores) are represented by rectangles. The two-headed arrows linking each of the 
latent variables represent the correlations among the factors.
The latent factor ‘Psychological state Time 2 ’ is comprised of the observed 
indicators Mood at time 2 (Mood2) and Self Efficacy at time 2 (Selfef2). Similarly, 
the latent factor ‘Psychological state Time 3’ is comprised of the observed indicators 
Mood at time 3 (Mood3) and Self Efficacy at time 3 (Selfef3). In addition, the scale 
of Non-catastrophic Thinking at time 3 (Uncata3) also loads on the psychological 
state factor at time 3. The adherence indicators of occasion of challenging thoughts
(cthocc3), frequency of challenging thoughts (cthoug3), frequency of stretching 
(stretc3), frequency of exercise (exerc3), occasion of pacing (paceoc3), and 
frequency of pacing (pace3) load onto the three adherence factors as described by the 
exploratory factor analysis. Err 1-err 11 are the error terms for the measures.
Figure 2: Measurement Model A, showing standardised coefficients. *p<0.05.
**p<0.01.
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Key: Mood2 =Mood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Mood3 =Mood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Cthocc3 =Occasion o f  
challenging thoughts (one-month follow-up); Cthoug3 ^Frequency o f challenging thoughts (one- 
month follow-up); Stretc3 =Frequency o f stretching (one-month follow-up); Exerc3 =Frequency of  
exercise (one-month follow-up); Paceoc3 =Occasion o f pacing (one-month follow-up); Pace3 
=Frequency o f pacing (one-month follow-up); Err 1-1 l=Error terms
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The confirmatory factor analysis resulted in a statistically significant chi-square 
value for this model (x 2 (34) =573.58, p<0.001). The fit of the Measurement Model 
A was also shown to be ‘not positive definite’, indicating that it was clearly miss- 
specified and that the solution was inadmissible. Examination of the correlations 
shown in Figure 2 between the latent factors ‘Psychological state Time 2’ and 
‘Psychological state Time 3’ showed the correlation to be 1.02. This correlation 
being greater than 1.0 indicated a problem of multicollinearity (Byme, 2001), 
whereby the observed variables were so highly correlated that they seemed to 
represent the same underlying construct. This was not surprising given that the 
underlying constructs in question were the same, but measured at different time 
points. Therefore post hoc modifications were required to find a measurement model 
that adequately fitted the data.
Post Hoc Adjustments
The measurement model was re-specified as shown in Measurement Model B 
(MMB) in Figure 3. As the same measures were administered at different time 
points for the psychological state factors, two correlations among their disturbances 
were allowed and tested. The two-headed arrows linking errl and err9, and err2 and 
err 10 represent the autocorrelations over time for the error terms for the Mood-time 2 
and Mood-time 3 variables, and for the Self-efficacy variables at each time point.
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Figure 3: Measurement Model B, showing standardised coefficients. *p<.05.
**p<0.01.
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Key: Mood2 =Mood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Mood3 =Mood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Cthocc3 ^Occasion of 
challenging thoughts (one-month follow-up); Cthoug3 =Frequency o f challenging thoughts (one- 
month follow-up); Stretc3 =Frequency o f stretching (one-month follow-up); Exerc3 ^Frequency of 
exercise (one-month follow-up); Paceoc3 =Occasion o f pacing (one-month follow-up); Pace3 
=Frequency o f pacing (one-month follow-up); Err 1-1 l=Error terms
A statistically significant chi-square value was again produced for this model (x 2 
(32) = 96.64, p<0.001). However, the chi-square statistic is unreliable for such large 
samples; therefore the fit of the revised Measurement Model B was assessed using a 
range of goodness of fit indices as shown in Table 8. Each of these implied a good 
fit; the x2/df ratio was 3.02, the CFI was 0.99 and the RMSEA was 0.04. All of these 
values indicated that the re-specified measurement model achieved a good fit of the 
data.
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The standardised estimates show that the value 0.83 is the correlation between 
Psychological state Time 2 and Psychological state Time 3. This indicates a 
tendency for patients who have higher levels of wellbeing post-treatment also to have 
higher levels of wellbeing at one-month follow-up. Figure 3 reveals that the 
psychological state post-treatment was significantly correlated with each adherence 
factor, indicating a tendency for patients who had higher levels of wellbeing to be 
more likely to adhere. It can be seen that all correlations between the latent factors in 
the model were highly significant, with only the correlation between psychological 
state post-treatment and cognitive adherence being weaker, although still significant 
(r=0.09, p=0.026). As expected, significant correlations were shown between the 
error terms of mood and self-efficacy at the two time points. This implies that the 
scales of mood and self-efficacy shared some variance over time that was not related 
to the psychological state factor. The R2 values for the mood measure at both time 
points indicated that 29% and 40% of the variance in this measure was shared with 
the psychological state factor at time 2 and time 3 respectively. These values 
therefore represented the reliability estimates of the Mood 2 and Mood 3 indicator 
variables respectively. All other indicator variables were seen to show much greater 
estimates of reliability (R2 values range from 54% to 79%), indicating that they more 
reliably measure the factors implied in the model. Since mood and self-efficacy 
scales are not designed to measure the same construct, it seems reasonable to believe 
that differences between them are due to more than just measurement error.
Therefore error terms represent not only measurement error, but every other variable 
that might affect scores on them besides psychological state, the major variable that 
affects them both.
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Table 8
Chi-Squared Values and Fit Indices for All Models
X*________df________ cmin/df CFI TLI RMSEA Hoelter’s
Measurement Models
MMA 575.58 34 16.93 0.90 0.81 0.12 102
MMB 96.64 32 3.02 0.99 0.98 0.04 576
MMC 34.28 6 5.71 0.99 0.97 0.06 442
MMD 4.18 5 0.84 1.00 1.00 0.00 3185
Structural Models
SM1 4.56 2 2.28 1.00 0.99 0.03 1581
SM 2a 4.95 2 2.48 1.00 0.99 0.04 1456
SM2b 9.62 5 1.92 1.00 0.99 0.03 1385
SM2c 25.97 10 2.60 1.00 0.99 0.04 849
SM2d 49.41 11 4.49 0.99 0.97 0.05 480
SM2e 37.40 11 3.40 0.99 0.98 0.05 633
SM 3a 0.90 1 0.90 1.00 1.00 0.00 5120
SM3b 6.40 4 1.60 1.00 0.99 0.02 1785
SM3c 13.06 9 1.45 1.00 0.10 0.02 1559
SM3d 25.15 10 2.51 1.00 0.99 0.04 876
SM3e 40.98 10 4.10 0.99 0.97 0.05 538
SM4a 0.82 1 0.82 1.00 1.00 0.00 5674
SM4b 23.21 4 5.80 0.99 0.95 0.06 492
SM4c 31.73 9 3.53 0.99 0.98 0.05 642
SM4d 53.11 10 5.31 0.99 0.96 0.06 415
SM4e 65.88 10 6.59 0.98 0.95 0.07 335
SM5a 40.00 15 2.67 0.99 0.98 0.04 752
SM5b 65.38 22 2.97 0.99 0.98 0.04 625
SM5c 91.10 35 2.60 0.99 0.98 0.04 658
SM5d 119.77 36 3.33 0.98 0.97 0.04 513
SM5e 123.87 36 3.44 0.98 0.97 0.05 496
Validation 87.44 35 2.50 0.99 0.98 0.04 701
Sensitivity 207.08 71 2.92 0.98 0.96 0.04 533
Key: X2 = Chi square value; df = degrees o f freedom; cmin/df = x2/degrees of freedom ratio; CFI = 
Comparative fit index; TLI = Tucker-Lewis index; RMSEA = Root mean square error of 
approximation; Hoelter's = Hoelter's critical sample size
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The Structural Models
Direct Pathway
In accordance with Holmbeck (1997), the first step in developing models which test 
mediation was to show that there was a direct causal effect between post-treatment 
outcome and one-month follow-up outcome to be mediated. Figure 4 shows 
Structural Model 1 (SM I) illustrating the hypothesised effect of post-treatment 
outcome on follow-up outcome. The output for this model is also illustrated in 
Figure 4. In SM I, the correlation among the factors has been replaced by a causal 
path (indicated by a one-headed arrow): the causal effect of psychological state post­
treatment on psychological state at one-month follow-up. For identification, an error 
term was added to the dependent variable, while other procedures for identification 
remained the same as for the measurement model.
Figure 4\ Structural Model 1, showing standardised coefficients. *p<.05. **p<0.01.
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Key: Mood2 =Mood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Mood3 =Mood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follcw-up); Err =Error terms
Fit indices (see Table 8) for Model SMI indicated an excellent fit. The causal effects
of psychological state post-treatment on psychological state at one-month follow-up
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were significant. Psychological state at the end of treatment was a statistically 
significant predictor of psychological state at one-month follow-up (3 = 0.83, SE 
=0.07, p<0.001). Therefore, a significant direct pathway from post-treatment 
outcome to one-month follow-up outcome was shown to exist. The regression 
analyses revealed that psychological state at the end of treatment explained 69% of 
the variance (R2=0.69) in psychological state scores at one-month follow-up.
Mediating Models
A series of models explored the mediating influences of cognitive adherence, 
physical adherence, and pacing adherence between post-treatment outcome and 
follow-up outcome individually, to initially investigate whether any of the types of 
adherence had a mediating impact on the relationship between psychological state at 
the end of treatment and at follow-up.
1.) Does Cognitive Adherence have a Mediating Role?
In line with Baron and Kenny’s (1986) steps to test for mediation, three separate 
causal models (path analyses) were run: see Models SM2a, SM2b and SM2c in 
Figures 5, 6 and 7 respectively. Model SM2a tests for an association between 
psychological state post-treatment and cognitive adherence, Model SM2b tests for 
the influence of cognitive adherence on psychological state at one-month follow-up, 
and Model SM2c tests the mediating pathway. Model SM2c is therefore based on 
the assumption that both psychological state post-treatment and cognitive adherence 
make independent contributions to psychological state at follow-up, and that 
cognitive adherence is predicted by psychological state post-treatment.
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Figure 5: Model SM2a, showing standardised coefficients. *p<.05. **p<0.01.
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Key: Mood2 =Mood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Cthocc3 =Occasion o f challenging thoughts (one-month follow-up); Cthoug3 =Frequency of 
challenging thoughts (one-month follow-up); Err =Error terms
Model SM2a shows a direct path from psychological state post-treatment to 
cognitive adherence. The total variance in cognitive adherence accounted for by this 
model was only 2% (R2=0.02), although fit indices (see Table 8) suggested a good 
fit. The model showed that psychological state post-treatment had a significant 
direct path to cognitive adherence (B=0.13, p<0.001).
In model SM2b cognitive adherence is assumed to predict psychological state at 
follow-up. The causal effect of cognitive adherence on psychological state at follow- 
up was 0.22 (p<0.01). The total variance in follow-up outcome accounted for by this 
model was 5% (R2=0.05), and again fit indices showed good fit. The model 
illustrated that cognitive adherence had a significant direct path to psychological 
state at follow-up.
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Figure 6: Model SM2b, showing standardised coefficients. *p<.05. **p<0.01.
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Key: Mood3 =Mood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month
follow-up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Cthocc3 ^Occasion 
of challenging thoughts (one-month follow-up); Cthoug3 =Frequency of challenging thoughts (one- 
month follow-up); Err =Error terms
Fit indices for Model SM2c show that this model also has good fit. Model SM2c 
output indicates that when the cognitive adherence factor was entered, psychological 
state post treatment was still a statistically significant predictor of psychological state 
at one-month follow-up (B=0.81, p<0.01) at one-month follow-up, although the 
strength of the relationship has decreased. From Figure 7 it is apparent that the 
introduction of the mediating variable is accompanied by a drop in the values of the 
regression coefficient (B=0.81, while in Model SMI B=0.83) representing the direct 
effect of psychological state post treatment on psychological state at one-month 
follow-up. This suggests that cognitive adherence partially mediates the relationship 
between these two variables. The total variance in psychological state at follow-up
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accounted for by this model was 70% (R2=0.70). Also, Figure 7 shows that the 
addition of cognitive adherence factor to the model only contributes an additional 1% 
of the explained variance in psychological state at one-month follow-up.
Figure 7: Model SM2c, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood2 =Mood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Mood3 =M ood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Cthocc3 =Occasion of 
challenging thoughts (one-month follow-up); Cthoug3 ^Frequency o f challenging thoughts (one- 
month follow-up); Err =Error terms
Comparison with nested models
Because the mediating role of cognitive adherence was not the only plausible model, 
model SM2c was compared with two nested models representing alternative 
hypotheses. Model SM2d (shown in Figure 8) assumes that psychological state time 
2 predicts cognitive adherence and psychological state time 3, but that no path
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between cognitive adherence and psychological state time 3 exists. By comparison, 
in Model SM2e (shown in Figure 9) psychological state time 2 and cognitive 
adherence are assumed to be related to psychological state time 3, but there is no link 
between psychological state time 2 and cognitive adherence. Fit indices reveal that 
both Model SM2d and SM2e fit the data adequately.
Figure 8: Model SM2d, showing standardised coefficients. *p<.05. **p<0.01.
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Figure 9: Model SM2e, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood2 =M ood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Mood3 =M ood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Cthocc3 ^Occasion of 
challenging thoughts (one-month follow-up); Cthoug3 =Frequency o f challenging thoughts (one- 
month follow-up); Err =Error terms
Because of differences in degrees of freedom between models SM2c and SM2d and 
between SM2c and SM2e, it was possible to compare these two pairs on the basis on 
change in %2. Model SM2c was a significantly better fit over Model SM2d, x2diff (1) 
= 23.44, pc.001, and over Model SM2e, x2diff (1) = 11.44, p<.001. Comparing fit 
indices also revealed that Model SM2c had a better fit. This again suggests that 
cognitive adherence has a mediating role in the relationship between psychological 
state post-treatment and psychological state at one-month follow-up.
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Does Pacing Adherence have a Mediating Role?
The path analyses reported above were re-run using the pacing adherence factor, to 
investigate whether it too had a mediating effect. Models SM3a, SM3b and SM3c 
are shown in Figures 10, 11 and 12 respectively. Each model was found to provide 
an excellent fit with the data, as shown from the fit indices detailed in Table 8.
Model SM3a in Figure 10 predicts that psychological state at time 2 effects level of 
pacing adherence. The total variance accounted for by this model was 4% (R2=0.04) 
and fit indices suggested an excellent fit. This model therefore implies that 
psychological state at time 2 has a significant direst path (13=0.21) to pacing 
adherence.
Figure 10: SM3a, showing standardised coefficients. *p<.05. **p<0.01.
Key: M ood2 =M ood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Paceoc3 ^Occasion o f pacing (one-month follow-up); Pace3 ^Frequency o f pacing (one-month 
follow-up); Err =Error terms
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Figure 11: SM3b, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood3 =M ood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month
follow-up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Paceoc3 ^Occasion 
o f pacing (one-month follow-up); Pace3 =Frequency o f pacing (one-month follow-up); Err =Error 
terms
Model SM3b in Figure 11 implies that pacing adherence has a direct association with 
psychological state at follow-up. The analyses reveals that pacing adherence is 
significantly related to psychological state at follow-up (B=0.27), and that pacing 
adherence accounts for 7% of its variance (R2=0.07). This implies that pacing 
adherence influences follow-up psychological state.
Finally, Model SM3c in Figure 12 illustrates the hypothesised mediating model; that 
psychological state at the end of treatment (post-treatment) directly effects 
psychological state at follow-up, but also that psychological state at the end of 
treatment effects psychological state at follow-up indirectly via pacing adherence. 
This model again showed good fit with the data. Psychological state post-treatment
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is seen to be a statistically significant predictor of psychological state at follow-up 
(6=0.81), and of pacing adherence (6=0.21). Pacing adherence was also shown to 
significantly predict psychological state at follow-up (6=0.10). Psychological state 
post-treatment and pacing adherence together account for 70% of the variance in 
psychological state at follow-up (R2=0.70).
Figure 12: SM3c, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood2 =Mood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Mood3 =M ood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Paceoc3 ^Occasion of 
pacing (one-month follow-up); Pace3 =Frequency o f pacing (one-month follow-up); Err =Error terms
Comparison with nested models
Models SM3d and SM3e illustrated in Figures 13 and 14 again illustrate nested 
models representing competing causal hypotheses. Each model showed good fit as 
indicated by the fit indices in Table 8. However, examination of the %2 differences
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between each of these models and SM3c revealed that model SM3c was a significant 
improvement on each of them (Comparing SM3c and SM3d, x2diff (1) = 12.08, 
p<.001, and comparing SM3c and SM3e, x2diff (1) = 27.92, p<.001). This confirms, 
as expected, that model SM3c, which assumes that pacing adherence has a mediating 
role between psychological state post-treatment and psychological state at follow-up, 
represents the best fitting model.
Figure 13: SM3d, showing standardised coefficients. *p<.05. **p<0.01.
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Figure 14\ SM3e, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood2 =M ood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Mood3 =M ood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Paceoc3 =Occasion o f  
pacing (one-month follow-up); Pace3 =Frequency o f pacing (one-month follow-up); Err l - l  l=Error 
terms
Does Physical Adherence have a Mediating Role?
As an initial step to explore the hypothesised mediating role of physical adherence on 
the relationship between psychological state post-treatment and psychological state at 
follow-up, physical adherence was regressed on psychological state post-treatment as 
shown in Model SM4a (Figure 15). Fit indices for this model indicated good fit with 
the data, and a significant direct path from psychological state post-treatment to 
physical adherence was implied (B=0.25). In addition, 6% of the variance in physical 
adherence was accounted for by this model (R2=0.06).
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Furthermore, Model SM4b in Figure 16 examines whether physical adherence 
predicts psychological state at one-month follow-up. It can be seen from this model 
that a significant direct relationship between these factors is implied (13=0.32), and 
that 10% of the variance in follow-up psychological state is accounted for.
Finally, Model SM4c (Figure 17) investigates the existence of a mediating effect of 
physical adherence on the relationship between psychological state post-treatment 
and psychological state at follow-up. The analyses revealed each direct path to be 
significant. Most importantly, the direct effect of psychological state post-treatment 
to psychological state at follow-up was shown to be reduced (13=0.80) in this model 
when compared to model SM I, in which no mediating variable is included. This 
implies that physical adherence partially mediates the relationship between these two 
variables. Also, the addition of physical adherence into the model results in 2% 
increase in the percentage of explained variance in psychological state at follow-up, 
with this model explaining 71% of its variance (R2=0.71).
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Figure 15: SM4a, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood2 =M ood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Stretc3 =Frequency o f stretching (one-month follow-up); Exerc3 =Frequency of exercise (one-month 
follow-up); Err =Error terms
Figure 16: SM4b, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood3 =M ood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month
follow-up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Stretc3 ^Frequency 
of stretching (one-month follow-up); Exerc3 =Frequency o f exercise (one-month follow-up); Err 
=Error terms
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Figure 17: SM4c, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood2 =M ood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Mood3 =M ood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Stretc3 ^Frequency of 
stretching (one-month follow-up); Exerc3 =Frequency o f exercise (one-month follow-up); Err =Error 
terms
Comparison with nested models
Models SM4d and SM4e illustrated in Figures 18 and 19 again illustrate nested 
models representing the competing causal hypotheses. Examination of the x2 
differences between each of these models and SM4c (the mediating model) revealed 
that model SM4c was a significant improvement on each of them (Comparing SM4c 
and SM4d, x2diff (1) = 21.34, p<.001, and comparing SM4c and SM4e, %2diff (1) = 
34.15, pc.OOl). Fit indices also point to model SM4c being the best fit with the data. 
This implies that physical adherence has a mediating role between psychological 
state post-treatment and psychological state at follow-up, and that Model SM4c 
represents the best fitting model.
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Figure 18: SM4d, showing standardised coefficients. *p<.05. **p<0.01.
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Figure 19: SM4e, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood2 =Mood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
M ood3 =M ood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Stretc3 ^Frequency of 
stretching (one-month follow-up); Exerc3 =Frequency o f exercise (one-month follow-up); Err =Error 
terms
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D oes Overall  Adherence have a Mediating Role?
The results of the previous models suggest that each adherence factor (cognitive 
adherence, pacing adherence, and physical adherence) independently have a partial 
mediating effect on the relationship between post-ireatment and follow-up outcomes. 
These path analyses therefore formed the basis for a final set of analyses to model the 
potential pathway from psychological state time 2 to psychological state time 3, with 
‘overall adherence’ mediating. A second order factor, ‘Overall Adherence’, was 
therefore developed prior to being used in this final set of analyses.
Second-Order Confirmatory Factor Analysis (CFA) Model 
Model MMC, shown in Figure 20, hypothesised that responses to individual 
adherence measures could be explained by three first-order factors (cognitive 
adherence, pacing adherence, and physical adherence), and by one second-order 
factor (overall adherence). Error terms associated with each item were hypothesised 
to be uncorrelated and covariation among the three first-order factors would be 
explained fully by their regression on the second-order factor.
Model MMC showed reasonable fit with the data as indicated by fit indices in Table 
8. However, given that the items ‘occasion of pacing’ and ‘occasion of challenging 
thoughts’ had both been rescaled within the study, the specification of an error 
correlation between them was substantiated. A correlation between err3 and err7 
was therefore allowed and the model was re-estimated in an effort to improve its fit, 
as illustrated in Model MMD (Figure 21).
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Figure 20: MMC, showing standardised coefficients. *p<.05. **p<0.01.
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Figure 2F. MMD, showing standardised coefficients. *p<.05. **p<0.01.
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Key: Cthocc3 =Occasion o f challenging thoughts (one-month follow-up); Cthoug3 ^Frequency of
challenging thoughts (one-month follow-up); Stretc3 =Frequency o f stretching (one-month follow- 
up); Exerc3 =Frequency o f exercise (one-month follow-up); Paceoc3 =Occasion o f pacing (one-month 
follow-up); Pace3 ^Frequency o f pacing (one-month follow-up); Err =Error terms
Model MMD showed an excellent fit, as shown by the x2-value and fit indices for 
this model in Table 8. The standardised estimates show that a significant correlation 
exists between the error terms err3 and err7. All factor loadings are also statistically
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significant. Therefore, on the basis of the adequacy of the fit statistics and 
standardised solutions, and because there is no justification for making further 
modifications, this model is considered to best represent the second-order structure 
of adherence items. It was therefore used as the basis of all subsequent structural 
models.
The first structural model to be tested that included the second-order factor ‘overall 
adherence’ is shown in Figure 22. Model SM5a examines the hypothesis that overall 
adherence is predicted by psychological state post-treatment. This model shows 
good fit with the data as indicated by fit indices in Table 8. 6% of the variance in 
overall adherence is accounted for by psychological state post-treatment (R2=0.06), 
and a significant regression coefficient (6=0.25) is shown.
Figure 22: SM5a, showing standardised coefficients. *p<.05. **p<0.01.
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Kex: M ood2 =Mood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Cthocc3 ^Occasion o f challenging thoughts (one-month follow-up); Cthoug3 =Frequency of  
challenging thoughts (one-month follow-up); Stretc3 =Frequency o f stretching (one-month follow- 
up); Exerc3 ^Frequency o f exercise (one-month follow-up); Paceoc3 ^Occasion of pacing (one-month 
follow-up); Pace3 =Frequency o f pacing (one-month follow-up); Err =Error terms
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Model SM5b (Figure 23) went on to test for an association between overall 
adherence and psychological state at follow-up. The total variance accounted for by 
this model was 13% (R2=0.13), and a significant direct path from overall adherence 
to psychological state at follow-up was found to exist.
Figure 23: SM5b, showing standardised coefficients. *p<.05. **p<0.01.
Key: Mood3 =Mood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month
follow-up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Cthocc3 ^Occasion  
o f  challenging thoughts (one-month follow-up); Cthoug3 =Frequency o f challenging thoughts (one- 
month follow-up); Stretc3 =Frequency o f stretching (one-month follow-up); Exerc3 =Frequency of 
exercise (one-month follow-up); Paceoc3 =Occasion o f pacing (one-month follow-up); Pace3 
=Frequency o f pacing (one-month follow-up); Err =Error terms
Figure 24 shows Model SM5c, which tests whether direct and indirect pathways exist 
between levels of psychological state at the two time points. This model represents 
the mediating model, i.e. that overall adherence has a mediating role in the 
relationship. Fit indices for Model SM5c show that this model has good fit. All 
standardised regression coefficients were shown to be significant indicating the 
following effects:
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• that psychological state post-treatment significantly predicts 
psychological state at follow-up;
• that psychological state post-treatment significantly predicts overall 
adherence;
• that overall adherence significantly predicts psychological state at 
follow-up.
The decrease in the strength of the relationship between psychological state post­
treatment and psychological state at follow-up, indicated by the drop in the 
regression co-efficient from 0.83 in SMI to 0.79 in SM5c, highlights the partially 
mediating role that overall adherence plays. Psychological state post-treatment and 
overall adherence is seen to account for 72% (R2 = 0.72) of the variance in follow-up 
wellbeing. This indicates that overall adherence explains an additional 3% of the 
variance in psychological state at follow-up that is not accounted for by previous 
psychological state.
Figure 24\ SM5c, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood2 =M ood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Mood3 =M ood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Cthocc3 =Occasion of 
challenging thoughts (one-month follow-up); Cthoug3 =Frequency o f challenging thoughts (one- 
month follow-up); Stretc3 ^Frequency o f stretching (one-month follow-up); Exerc3 ^Frequency of 
exercise (one-month follow-up); Paceoc3 =Occasion o f pacing (one-month follow-up); Pace3 
=Frequency o f  pacing (one-month follow-up); Err =Error terms
Comparison with nested models
Because the mediating role of overall adherence was not the only plausible model, 
model SM5c was compared with two nested models representing alternative 
hypotheses. Model SM5d (shown in Figure 25) assumes that psychological state 
time 2 predicts overall adherence and psychological state time 3, but that no path 
between overall adherence and psychological state time 3 exists. By comparison, in 
Model SM5e (shown in Figure 26) psychological state time 2 and cognitive 
adherence are assumed to be related to psychological state time 3, but there is no link 
between psychological state time 2 and cognitive adherence. Fit indices reveal that 
both Model SM5d and SM5e fit the data adequately.
That said, change in x2 between each of these models and SM5c showed that each 
was significantly worse when compared to SM5c. Model SM5c was a significant 
improvement over SM5d, x2diff (1) = 28.67, p<.001. Similarly, Model SM5c was a 
significant improvement over SM5e, x2diff (1) = 32.77, p<.001. Comparison of 
various fit indices also reveals that Model SM5c is a better fit. These results were 
consistent with the hypothesis that adherence is influenced by psychological state, 
and that adherence has a causal effect on later changes in psychological state.
These results suggest Model SM5c should be considered to be the final overall causal 
model in the study. This model implies that psychological state at the end of
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treatment is directly related to psychological state at one-month follow-up, and that 
this relation also functions via overall adherence. All causal paths in this model were 
shown to be significant, suggesting that there is a strong relationship between 
psychological state at the two time points and overall adherence. This model 
therefore suggests that patients who adhere to treatment recommendations are likely 
to maintain their treatment gains while patients who do not as less likely to maintain 
their gains. Of course, the effect of adherence does not disqualify the effect of 
psychological state post-treatment having a strong direct causal effect on 
psychological state at follow-up.
Figure 25: SM5d, showing standardised coefficients. *p<.05. **p<0.01.
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Figure 26: SM5e, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood2 =M ood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
Mood3 =M ood at time 3 (one-month follow-up); Selfef3 =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Cthocc3 =Occasion of 
challenging thoughts (one-month follow-up); Cthoug3 =Frequency o f challenging thoughts (one- 
month follow-up); Stretc3 =Frequency o f stretching (one-month follow-up); Exerc3 ^Frequency o f  
exercise (one-month follow-up); Paceoc3 =Occasion o f pacing (one-month follow-up); Pace3 
=Frequency o f pacing (one-month follow-up); Err =Error terms
Model Validation
Cross-validation of the final model (SM5c) was conducted using the split sample 
(N= 1231) as post-hoc modifications had been made to the model. Figure 27 
illustrates the final model, tested on the validation sample. Fit indices revealed of 
this model again showed good fit. All pathways remained significant in this model. 
The similarity between the outputs from this final model between the exploratory and 
validation groups indicates that this model is valid beyond the sample it was 
developed on.
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Figure 2 7 \ Validation Model, showing standardised coefficients. *p<.05. **p<0.01.
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Key: M ood2 =M ood at time 2 (post-treatment); Selfef2 =Self efficacy at time 2 (post-treatment);
M ood3 =M ood at time 3 (one-month follow-up); Selfef? =Self efficacy at time 3 (one-month follow- 
up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Cthocc3 =Occasion of 
challenging thoughts (one-month follow-up); Cthoug3 =Frequency of challenging thoughts (one- 
month follow-up); Stretc3 ^Frequency o f stretching (one-month follow-up); Exerc3 ^Frequency of 
exercise (one-month follow-up); Faceoc3 =Occasion o f pacing (one-month follow-up); Pace3 
^Frequency o f pacing (one-month follow-up); Err =Error terms
Sensitivity Testing
As a test of sensitivity, the following demographic variables were included in the 
model: age; gender; education level; and site of pain. These variables were 
correlated with psychological state post-treatment and had causal effects on 
adherence and on psychological state at one-month follow-up, as shown in Figure 28. 
As no differences were detected between the outcomes of the final model when 
tested on the two distinct samples, only the exploratory sample was used during the 
sensitivity testing stage.
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The fit of this model was good. This sensitivity test indicated that the effect of 
psychological state post-treatment and overall adherence on psychological state at 
follow-up was independent of the effects of the demographic variables. This can be 
concluded as parameter estimates do not appear to have been influenced by the 
inclusion of the other variables. The causal effect of overall adherence on 
psychological state time 3 remained significant (CR=5.33, p<.0001); and the 
parameter value of 0.17 (SE =0.08) was also comparable. Neither age nor sex were 
shown to be significant predictors of psychological state at follow-up, and neither 
site of pain nor age left school were significantly related to overall adherence. This 
implies that psychological state at follow-up and overall adherence are not influenced 
by these demographic variables.
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Figure 28: Final Model with Sensitivity Testing, showing standardised coefficients.
*p<.05. **p<0.01.
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up); Uncata3 =Non-catastrophic thinking at time 3 (one-month follow-up); Cthocc3 ^Occasion of 
challenging thoughts (one-month follow-up); Cthoug3 =Frequency o f challenging thoughts (one- 
month follow-up); Stretc3 =Frequency o f stretching (one-month follow-up); Exerc3 =Frequency of 
exercise (one-month follow-up); Paceoc3 =Occasion o f pacing (one-month follow-up); Pace3 
=Frequency o f  pacing (one-month follow-up); Err =Error terms
4 Discussion
The purposes of this study were to investigate the multidimensionality of adherence 
as a theoretical construct using exploratory factor analysis, and to compare several 
causal models which relate adherence to outcome. The study aimed to examine the
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extent to which cognitive adherence (continued use of thought challenging 
techniques) and behavioural adherence (continued use of stretch, exercise, and 
activity pacing) after discharge from cognitive-behavioural rehabilitative group 
treatment for persistent pain, predicts outcome at one-month follow-up. Structural 
equation modeling was used to assess to what extent, if any, adherence contributes to 
the prediction of outcomes at one-month follow-up. The research highlights the 
successful application of complex modeling techniques to meet these aims.
The first finding of this study concerned the multidimensionality of adherence as a 
construct. The exploratory factor analysis provided a clean solution indicating that 
the adherence measures loaded on to three adherence factors: physical adherence; 
pacing adherence; and cognitive adherence. The clarity of loadings and the absence 
of substantial cross-loadings identified this solution to be excellent, and so it was 
used confidently throughout the subsequent analyses.
The primary finding of the present study was that each factor of adherence was 
independently shown to partially mediate the relationship between psychological 
state post-treatment and psychological state at one-month follow-up.
In support of the findings of Fielding and Duff (1999), and Fraser et al. (2003), levels 
of mood and self-efficacy were shown to contribute to the prediction of adherence. 
Similarly, in line with the findings of Nicholas et al. (1991), the results obtained are 
supportive of the hypotheses that cognitive adherence, pacing adherence and physical 
adherence each contribute to the prediction of one-month follow-up outcomes. That 
said, the percentages of variance in one-month follow-up outcome accounted for by 
the adherence factors were shown to be small, with each type of adherence only
131
accounting for an additional 1-2% of the explained variance in psychological state at 
follow-up.
Experts in the field of persistent pain have reported that from clinical experience 
patients often identify activity pacing as the strategy which most helps them post­
treatment. Various reasons can be provided for this, including that pacing gives 
patients a scheme to work to which may reduce worrying and rumination. It can also 
enable patients to plan better and to do more than they feel capable of judging by 
pain alone. This in turn helps patients with persistent pain to avoid vigilance to and 
monitoring of pain, which may contribute to catastrophising. Finally, pacing 
provides patients with permission to stop before completing tasks without accusing 
themselves of failure. It is interesting therefore that pacing adherence did not 
account for a more substantial percentage of variance in follow-up outcome than 
revealed by this study. It seems that despite patients placing more emphasis on 
pacing as the method that helps, each type of adherence (physical, cognitive, and 
pacing) has an equal impact on influencing maintenance of treatment gains.
However, some patients may be using activity pacing counterproductively to keep 
their activity levels low rather than to build up, and some have few activities that 
they enjoy. These issues must be taken into account when interpreting the findings.
A third finding was that overall adherence was shown to partially mediate the 
relationship between psychological state post-treatment and at one-month follow-up. 
When psychological state at follow-up was regressed on psychological state post­
treatment, psychological state post-treatment was revealed to account for 69% of the 
variance in psychological state at follow-up. However, when overall adherence was
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added into the model, 72% of the variance in psychological state at follow-up was 
accounted for, indicating that overall adherence accounted for an additional 3% of 
the variance. This finding highlights the relatively small yet significant impact that 
adherence has on follow-up outcome.
In hypothesising about why the amount of variance accounted for by adherence was 
shown to be small, one argument stands out. It may be that improvement after the 
end of treatment happens over a longer time span, and that more variance in follow- 
up outcome may be attributable to adherence over 3 months, for example. The 
present study was unable to examine this hypothesis because of the extent of missing 
data at longer-term follow-up.
The results of this study suggest that a patient’s psychological state post-treatment 
has more influence on follow-up psychological state than the extent to which s/he 
adheres to treatment recommendations. This suggests that it may be that getting 
patients to as high a level as possible at discharge is more productive than in 
allocating more time and resources to encouraging patients to adhere to treatment 
methods.
Validation of the model was important as empirically based re-specifications to the 
model could have led to capitalization on chance and over-fitting of the model. The 
cross-validation strategy used in this study meant that the model was developed with 
a split-half of the sample, and it was validated using the remainder of the sample. 
Testing of the final model on a split half of the sample revealed that the validity of 
the model was good. However, model fit was cross-validated using a nested sample,
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which has implications for the generalisability of findings. For example, the results 
of this study can only be used to draw conclusions about the impact of this particular 
treatment programme on adherence and outcomes. The validity of the model can 
only be demonstrated by the weight and convergence of a future body of research, 
and cross-validation with an independent sample is required to test whether the 
findings of this research are truly generalisable to other populations.
Finally, the sensitivity of the model was shown to be good, as the addition of these 
other variables in the model did not reveal any missing variable bias. This implies 
that these were not important missing variables from the model which might have 
biased results. The sensitivity testing was also important to indicate that 
psychological state at follow-up is not dependent on age and sex. This has clinical 
implications, as it suggests that services should not exclude patients from treatment 
on the basis of age or sex.
SEM was the method chosen for testing for the mediation role of adherence on 
follow-up outcome. It combines multiple regression and factor analysis procedures, 
it simultaneously estimates multiple regression equations, and it avoids problems of 
over- and under-estimating effects by controlling for measurement error (Baron & 
Kenny, 1986). SEM techniques were used as opposed to regression methods as they 
provide a less biased assessment of mediator effects, and because it is the preferred 
approach when multiple indicators are available for each latent variable (Tabachnick 
& Fidell, 2001). It also allowed for the estimation of a model that modelled for 
multicollinearity. Alternative statistical procedures such a multiple regressions 
would have required separate tests of model components conducted on an equation-
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by-equation basis, rather than of the model as a whole. This would have had 
implications for type one error.
Limitations
The results of the study should be interpreted in view of the following limitations. 
Research design and sample limitations
The ability to infer causality is tied most fundamentally to research design, not 
statistical analyses. One concern is that measures of one-month outcomes and 
adherence were obtained concurrently. Participants were therefore asked to recall 
their current levels of adherence at the same point at which follow-up outcome data 
were collected. This raises two important considerations. Firstly, as noted by Cole 
and Maxwell (2003), a retrospective measure of adherence may well be biased by the 
outcome that it claims to predict. Secondly, it was not possible to conclude whether 
adherence actually caused psychological state at follow-up or vice versa. Therefore, 
the direction of causality cannot be determined definitely. Ideally, adherence should 
have been measured at a time before the outcome variables, so that data would have 
been collected in a fashion that allowed time to elapse between the theoretical cause 
(adherence) and its effect (long-term outcome). To infer causality, it must be 
demonstrated that the cause precedes the effect. Further analyses would be needed to 
substantiate that adherence caused follow-up outcome. For example, use of a cross­
lagged panel design could have been used to infer causal paths, to show that 
adherence caused outcome and not vice-versa.
135
Although utilising a large data sample during the analyses brought with it many 
advantages, it is important to also note the problems that may have arisen from using 
such a large sample. Firstly, the correlation analyses revealed statistically significant 
correlations between variables, but substantive significance should not be assumed 
merely because statistical significance was demonstrated. For large samples, even 
very weak relationships may be shown to be statistically significant. Secondly, the fit 
of the models was assessed using the likelihood ratio chi-square statistic, and other 
indices of fit. The problem of the chi-square fit index is that the larger the sample, 
the more likely the rejection of the model and the more likely the Type II error. This 
index is also very sensitive to violations of the assumption of multivariate normality, 
and it is affected by the size of the correlations in a model (Tabachnick & Fidell, 
2001). In this study, the large sample size and the strong correlations between latent 
variables may have contributed to the large, significant chi-squared values. The fit 
indices utilised to indicate model fit should also not be regarded as perfect measures 
of model suitability. These indices were simply a tool to enable the conclusion that a 
well-fitting model is one plausible representation of the underlying structure.
The current study only utilised follow-up data collected one-month after treatment 
had ended. Although some long-term follow-up outcome data were available, it was 
decided that it was not appropriate to use it in the current study due to large 
percentages of missing data and inconsistencies in the data collection. The present 
study was therefore unable to examine the role that adherence may play in longer- 
term outcome. The analysis of long-term follow-up data (e.g. collected one year 
after treatment) would have enabled the final model to be tested to examine whether 
adherence to treatment recommendations continues to have an influence on
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maintaining treatment gains in the long-term. This of course would have been of 
benefit in the current study. Although extended follow-up periods are suggested to 
research the long-term outcome of treatments, the longer the follow-up period, the 
harder it is to determine whether outcome is due to the given factor under 
investigation. Therefore, results from very long-term follow-up studies may be 
difficult to interpret and caution would have been necessary when interpreting 
findings on the influence of adherence on longer-term outcome.
The present study examined the role that adherence to treatment methods had in 
relation to psychological state only. It was useful to illustrate that psychological 
state does not only arise from using cognitive methods, but from an interaction of 
various behavioural and cognitive strategies. However, what is missing from the 
current research findings is information concerning the relationship of adherence to 
other important outcomes such as physical wellbeing and experience of pain.
The study was not able to test the hypothesis of Erlen and Caruthers (2007), that 
adherence predicts adherence. Further research is necessary to focus on and examine 
the influence that adherence has on other outcome domains, and to examine whether 
adherence at one point is associated with levels of adherence at a later point.
Despite the very good fit of the models examined in this study and the use of 
sensitivity testing, it is possible that important constructs (e.g. motivation level or 
amount of social support) may have been omitted from the model that in reality are 
implicated in the causal structure. Therefore the final model from this study is 
unlikely to provide a complete account of the causes of one-month follow-up
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outcome. Although residual variance and covariance terms allowed the modeling of 
the effects of omitted variables, if important variables were omitted, inaccuracies on 
estimates, standard errors and inferences about causal structure are likely. Sensitivity 
analyses were used to assess the possible biases induced by omitting variables on 
regression coefficients, although only a handful of possible omitted variables were 
tested.
Measurement Limitations
Measurement methods must be valid, reliable and sensitive to change if they are to 
be employed w ith confidence (Tabachnick & Fidell, 2001). A number of 
measurement limitations may have contributed to bias in the current research 
findings, or may have restricted the conclusions that are able to be drawn from this 
study. Two of these limitations will be discussed in detail below.
The first measurement limitation concerns the choice of measures available for the 
study. As this was a study using existing data there was a limited choice of process 
and outcome measures available. Models therefore had to be developed around what 
measures were available, rather than the hypothesised model dictating which 
measures should be used. This meant that the development of latent constructs and 
models was restricted. For example, the latent construct of psychological state was 
very broad as only one measure of each more distinct latent construct (e.g. 
depression) was taken. Normally latent variables are developed by having multiple 
measures of the same distinct construct. For example, Hoyle and Gregory (1994) 
proposed that each latent variable should be uniquely represented by three or more
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indicators. As these were not available the reliability of the indicators, particularly 
for the psychological state constructs, could be called into question. Being 
constrained by available measures also meant that other potentially theoretically 
interesting process factors, such as perceptions of helplessness, could not be included 
in models. Even where crucial measures were available for use, they were not 
without their limitations.
Secondly, it is crucial to note that self-report measures of adherence were used in the 
study. Although self-report measures have the advantage of ease of administration 
and coding, the use of a self-report measure of adherence assumes that a participant 
truthfully reports his/her adherence. The disadvantages of self-report data include 
the response biases of social desirability and demand characteristics. For example, 
using a self-report method it has been shown that patients under-report non­
adherence, especially if there is a therapist expectation of high adherence. Self- 
report also requires accurate recall by participants. In this study specifically, patient 
reporting of adherence may have been influenced by their psychological state at 
follow-up, as they were measured concurrently. For example, a participant feeling in 
a particularly good mood may be more likely to report good adherence. It has been 
argued that self-reporting therefore overestimates adherence (Kenna, Labbe, Barrett, 
& Pfister, 2005), and the reliability and validity of the measures of adherence could 
be questioned, because of response biases such as social desirability, recency effects, 
and acquiescence. To increase the reliability of adherence measures, if running this 
study again, additional adherence ratings from a partner or friend of the participant 
would be beneficial. Alternatively, overt behaviours may have been assessed more 
objectively by an independent check or use of electronic readers such as pedometers.
139
Finally, thought diaries and physical exercise records could also have been utilised in 
the study to provide more detailed records of adherence over a given period. Such 
methods would be preferable as they do not depend on recalling levels of adherence 
retrospectively. Although time consuming and costly, such modifications may have 
resulted in more reliable measures of adherence. However, these methods also put 
considerable burden on the participant, which may limit their use to highly 
motivated, literate participants who are doing well after treatment. Consequently, 
they may not represent the full sample of treated patients. The best strategy for 
assessing adherence may have involved a combination of both self-report and 
objective measures.
Clinical Implications
In spite of the above limitations, this study made unique contributions: It was the first 
study to demonstrate using structural equation modeling the possible linkages among 
adherence and psychological state at different time points. The current study 
indicated that psychological state at the end of treatment was associated with 
adherence and that adherence was related to follow-up levels of wellbeing. It also 
demonstrated the influence that psychological state post-treatment has directly on 
psychological state at one-month follow-up. The use of a large clinical dataset 
ensured that the results had maximum external validity and clinical relevance.
These findings contribute to a theoretical framework which has implications for 
treatment content and for pain management practice and education. For example, to 
improve patient adherence staff might increase the emphasis they place on 
encouraging and educating patients on the importance of adhering to treatment
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recommendations. The findings can therefore inform efforts to enhance patient 
adherence.
The results of this investigation also indicate that it is important for patients to reach 
as high a psychological state by the end of treatment as possible. This information 
could be used to educate and motivate patients during the treatment phase, and it also 
has implications for informing treatment delivery. For example, intensive treatment 
programmes would be suggested as they have been shown to result in increased gains 
by the end of treatment, when compared with less intensive, outpatient programmes 
(e.g. Williams, Richardson, Nicholas, Pither, Harding, Ridout, Ralphs, Richardson, 
Justins & Chamberlain, 1996). The argument for an intensive treatment approach 
would endorse that the better the state of a patient by the end of treatment, the more 
likely it may be that everyday life presents reinforcements for managing pain 
successfully and for returning to a more normal lifestyle. For example, lifestyle 
changes could render exercises unnecessary in terms of formal practice as taught on 
the programme, because the patient is more active on a day-to-day basis. In this 
way, the gains of treatment may be sustained, not by the specific means taught on the 
programme, but by everyday exercise such as walking the dog or climbing stairs. 
However, such a proposal contradicts the recent government initiative to priorities 
Expert Patient Programmes, in the form of self-management groups, as the answer to 
all chronic physical problems (Department of Health, 2001).
Future Research
The links between adherence and psychological state at follow-up definitely warrant 
further exploration and several recommendations can be made to direct future
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investigations in this area. Firstly, there is clearly a need for validated measures of 
adherence to be developed as adherence is a multidimensional construct that may 
apply somewhat differently across various components of treatment. If better 
methods of measurement were available, it may be possible to examine whether there 
is a minimum level of adherence which is necessary for maintenance, and a 
maximum beyond which no further gains are made. There is also the possibility of 
an interaction effect, where those doing well at the end of treatment might need to 
adhere less than those who are doing less well, as everyday life may involve 
activities that promote maintenance for the former. The examination of hypothesised 
non-linear relations using SEM could be the focus of further investigations (Bauer, 
2005).
Secondly, the examination of the final model’s applicability in other samples would 
be useful. It is recommended that the model be tested using different independent 
data sets to examine the validity and reliability of its inferences further. Replication 
will be important to validate and support the findings of this study.
Once the findings of this study have been replicated with an independent sample, 
future research could focus on further developing the structural model to include 
other important variables that were omitted in the current study. For example, more 
focus could be put on identifying predictors of adherence, such as motivation levels 
and treatment satisfaction levels. In addition, change scores from pre- to post­
treatment could be incorporated into the model to examine whether the amount of 
change achieved during treatment influences adherence. The model could also be 
examined to compare whether different lengths of treatments influence adherence.
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Finally, adding pre-treatment measures into the model could help to understand more 
about change that happens during treatment, rather than just about change after 
treatment. Another method that could be used to shed light on the trajectory of 
change during treatment is the use of case tracking methods. For example, by taking 
session by session counts of exercise.
Future studies could examine the influence of adherence on longer-term follow-up 
outcome. Predicting long-term psychological state would require that a range of 
individual, familial, social, community and cultural factors be taken into account in 
the model. Future research should investigate the influence of adherence overtime 
more robustly.
Finally, SEM is unable to confirm definitely that a given model is a correct 
representation of the measurement or causal structure in the population. Equivalent 
models should be considered. It is suggested that future studies should be conducted, 
explicitly designed to discriminate plausible alternatives to the target model.
Conclusions
In summary, the present study is the first to investigate the predictive role of 
adherence on follow-up outcomes, using complex statistical procedures. Patients 
with persistent pain are a diverse group, so large sample sizes were necessary. The 
current data set was helpful in addressing the research questions and was valuable in 
providing evidence in support of the hypothesis that adherence is influenced by 
psychological state at the end of treatment, and it in turn influences follow-up
143
outcomes. Adherence was revealed to partially mediate the relationship between 
psychological state post-treatment and psychological state at one-month follow-up.
SEM methods represented an appropriate method to the study of mediation. To 
obtain more conclusive results regarding the causal associations between adherence 
and follow-up outcomes more highly refined studies will be needed to confirm these 
results in the future. Further research will also be necessary to investigate the 
potential role that adherence may play to longer-term follow-up outcomes.
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Part 3: Critical Appraisal
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Introduction
My experience of conducting this piece of research can only be described as a roller 
coaster ride, with emotions ranging from despair, frustration, and utter confusion, to 
joy, satisfaction and relief -  and not necessarily in that order! Completing the 
appraisal will give me the opportunity to discuss some general concerns about using 
an existing data set for the study. It will also allow me to explain why certain 
decisions were made during the process and to share some of the lessons I will be 
taking away with me from this experience. Finally, the appraisal will provide me 
with a chance to reflect on the process of conducting this piece of research.
General Concerns
One of the distinguishing features of this study was that it utilised an existing data set, 
rather than data that were collected by me, specifically for this study. Although using 
an existing data set brought with it many advantages, one issue that stands out for me 
is how difficult it was to familiarise myself with the data. Thinking back, using the 
existing data set would have been impossible had my supervisor not had detailed 
knowledge of the data, and the service from which it came. Because of her expertise 
with the data and of the procedures used at the pain management programme 
concerning patient care and data collection I was able to develop my own 
understanding of the data relatively quickly. However, it was vital to be able to have 
discussions with my supervisor regarding any issues that raised concerns as and when 
they arose. One such concern was about whether my research would meet the criteria 
for a Doctor of Clinical Psychology (D.Clin.Psy) thesis.
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As a result of using an existing data set it was a requirement that I made my statistics 
‘complex’, ‘sophisticated’, and impressive enough to compensate for not collecting 
the data myself. This raised alarm bells for me as unfortunately it was not clear what 
level of sophisticated statistics would be ‘good enough’ to meet the requirements for 
a D.Clin.Psy. This study was different to many D.Clin.Psy. projects as in my study 
the majority of time was spent planning, executing, and interpreting the statistical 
analyses, rather than on planning and executing data collection. However, it made 
sense for me to use a huge existing data set, where there was the possibility to use 
much neglected large sample statistical procedures. The alternative would have been 
to collect my own small sample, which is often the only option given the limited 
time-frame for completing a D.Clin.Psy. research project.
A final general concern that stands out for me is the rather shocking lack of valid and 
reliable measures that are found within adherence research. It seems astounding to 
me that despite CBT expecting lasting change in behaviour(s) and cognition, no 
standard ways of assessing whether those are happening seem to exist. Where 
measures of adherence do exist, they focus on frequency of adherence, rather than for 
example on the quality, effectiveness, or the appropriate use of the strategies. The 
development of reliable and standardised measures of adherence behaviour will be 
essential in the future if research findings are to be comparable across studies.
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Dilemmas
Many important decisions had to be taken over the course of the research period. 
These decisions included ones about which statistics techniques, statistical software, 
and cases and measures from the archival data to use. I would like to try to explain 
why such decisions were made.
One of the first decisions to be made was to decide whether SEM was the most 
appropriate statistical approach to investigate my hypotheses with the given data. 
There seemed to be so much to think about. The more I read, the more I felt confused 
and worried that it may not be an appropriate approach to use. My decision to use 
SEM as opposed to multiple regression procedures was made based primarily on the 
fact that SEM could simultaneously estimate multiple regression equations, while 
also controlling for measurement error. This ensured that my findings were as 
unbiased as possible.
When SEM had finally been decided upon, the next decision concerned choosing 
which statistical software package to use to conduct the analyses. I remember feeling 
unqualified to be making such a decision, especially when it was important to also 
consider financial costs. LISREL, EQS and AMOS statistical packages were each 
investigated and all had their advantages and disadvantages (Tabachnick & Fidell, 
2001). AMOS was the package of choice because of its graphical interface, because 
of its ability to handle missing data, and because it was already available for use 
within the University College London (UCL) clinical psychology department.
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Next, the decision about which data to use had to be made. For example, data were 
available on patients who had taken part in a 4-week (16-day) and a 2-week (9-day) 
inpatient programme, and I had to decide whether to use a combined set rather than 
only one or other of them. The decision to include data from the 4-week inpatient 
treatment group and the 2-week inpatient treatment group combined was difficult to 
make. For maximum homogeneity of experience I understand that it would have 
been beneficial to include only participants from one of these groups, and to have 
dropped the data from the other. However, this would have meant that much valuable 
data on adherence would have been lost. My decision to include both of these 
populations as a single group was based on my understanding that both were inpatient 
groups, in which massed practice behavioural change was encouraged. Also, as my 
interest was in adherence after treatment, rather than change during it, my decision to 
include both populations seemed justified. Another strategy may have been to 
include both treatment groups but to include treatment group as a variable of interest,
i.e. to compare the model between the two groups. However, as no previous research 
in persistent pain has explored the relationship between adherence and follow-up 
outcome it was important to include as much information as possible in developing an 
initial model. It was also thought that this would help to increase the generalisability 
of the research findings. Other information that informed this decision included that 
the 2-week inpatient group was much smaller than the 4-week sample, and that there 
was no clear hypothesis about what the differences would be between these two 
treatment groups. It was therefore decided that it would be more beneficial to look at 
the relationship of adherence to outcome overall in the first instance, using as large a 
data sample as possible. Perhaps a comparison of the role of adherence to follow-up 
outcome within different treatment groups could be conducted as a follow-up study.
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A huge array of measures was collected routinely from patients and I deliberated 
about which measures it would be best for me to use. In many cases I felt that I had 
to make the best of measures available, but I also had to make the difficult decision 
about which potentially valuable and interesting measures to drop. One example of 
having to make the best of what I had can be seen in the decision to combine scores 
from the pain catastrophising scale (PCS; Sullivan et al. 1995) and the coping 
strategies questionnaire (CSQ; Rosenstiel & Keefe, 1983). Had scores on only the 
PCS or only the CSQ been used the final dataset would have contained a vast amount 
of missing data. This would have meant that valuable information on the influence of 
catastrophising would have been unnecessarily lost.
In terms of dropping variables, reported frequency of relaxation, quality of life data 
(as measured by the SF-36; Ware & Sherboume, 1992), and data on physical 
functioning (as measured by walk distance) were each dropped from the study. 
Relaxation was left out as it was decided that there was no way to tell exactly how 
individuals were using it. The SF-36 quality of life measure was dropped as this 
information was not collected consistently from clients over the given time period.
For example, the measure was not taken post-treatment. Also, eyeballing of the data 
available revealed that the data contained repeated subject numbers. This meant that 
the data were not considered to be reliable. Finally, walk distance was initially 
recorded in 10-min, and was then changed to 5-min after the first 700 patients. The 
reliability of these data were also called into question as eyeballing of the data 
revealed that many patients with chronic pain had been recorded as having walked 
over 600m in 5-minutes. These distances seemed overly large. As there was no way
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to double check the reliability of these data it was decided that it was safer to drop 
this measure.
My decision to cut the sample size from its original size of 3948 participants to 2345 
was based on concerns about the amount of missing data within the sample. The 
decision was therefore made to only keep cases for which adherence data were 
available. It was decided that as adherence was my variable of interest it made little 
sense to include cases which included data on outcome, if they then did not have 
adherence data. Although this reduced the sample size and meant that some 
potentially valuable information was lost, it was necessary to lower the percentages of 
missing data to acceptable levels for analysis. This still left a substantial sample size 
of 2435 participants, which was more than adequate to conduct my analyses.
Concerns about missing data also had a part to play in determining which data- 
collection time-points would be used in the study. Data were available at pre­
treatment assessment (5 days before treatment), at post-treatment assessment (last day 
of treatment), and then they were available at one-month, six-month, nine-month and 
12-month follow-up. It was decided that pre-treatment outcomes would not be 
modelled as my interest was in change after treatment, rather than in change during it. 
The decision was made to use only the measures collected at post-treatment and one- 
month follow-up (and to model the relationship between them), for the following 
reasons. Firstly, it was only data collected at post-treatment and at one-month follow- 
up that were collected consistently over the course of the data collection period. By 
contrast, data were only occasionally collected at 6-month, 9-month and 12-month 
follow-up and never at all three time-points, which meant that any long-term follow-
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up data would have had to have been a combined form from each of these time 
points. For example, 6-month and 12-month follow-up data were only collected for 
the first 700 patients, with only 20% of these having completed the measures. 1000 
participants had completed some outcome measures at 9-month follow-up, although, 
again the percentages of missing data for individual measures were very high (50- 
80% missing data). The amount of missing data at these later time-points was 
therefore great, and the decision to leave them out was made. The decision to drop 
the long-term follow-up data was also based on two considerations: that the missing 
data at that time-point was not missing at random; and that there may have been too 
little variance at this point as only those doing well may have come back. In addition, 
long-term follow-up data were not used as any model examining change over that 
time span would have needed to model the influence of many external variables 
which were not measured. For example, variables such as paitner/family support and 
employment prospects may have had a significant impact on longer-term follow-up 
outcomes. This would have meant that the effect of adherence would have been 
weaker. Finally, increasing heterogeneity at that time would have meant that my final 
model was inadequate to test the influences of adherence on outcome at long-term 
follow-up. A more inclusive model of what leads to long-term behaviour change 
would be required, which was beyond the scope of the current study.
Another crucial decision had to be made regarding the methods utilised in 
determining latent variable structure. Factor analysis was chosen as the method for 
the adherence measures. This was appropriate as multiple measures of adherence 
were available and factor analysis illustrated clearly the factors that those measures 
loaded on to. In contrast, for the psychological state measures, only one outcome
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measure for each distinct latent construct (e.g. depression) was available and too few 
measures, even of the broader latent variables, were taken at each time point to allow 
for the use of factor analysis. My decision to load mood and self-efficacy together 
was therefore justified on the grounds that they were identified to correlate well. In 
addition, it was considered acceptable as it made logical and theoretical sense to 
combine measures as I did. It could be argued that the construct of ‘psychological 
state’ used in my study was too broad as mood and self-efficacy measures are 
designed to measure different things. I realise that this situation was not ideal, but as 
only one indicator for each specific construct was available I had to make do.
Finally, when first thinking about potential hypothesised models to examine, very 
elaborate models were conjured up. I wanted to include everything in my model. I 
wanted to test how the latent construct of psychological state was related to physical 
wellbeing and experience of pain, and how each of these was associated with each 
type of adherence. I wanted to include how patient satisfaction and expectations for 
treatment influenced these associations. However, I soon realised that I had 
unrealistic expectations of what could be achieved. After much consideration I 
decided that in order for the examiners and me to understand and follow the research 
process I was going to have to simplify things and lower my expectations of what 
could be achieved within the time scale, and with my knowledge of SEM.
I decided that rather than throwing everything into my models, I would build them up 
slowly so that I could assess at each point where any difficulties lay. Looking back, 
my original strategy of throwing everything into a model would surely have left me 
feeling overwhelmed and unable to explain the output. My approach instead allowed
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the models to be developed in discrete, logical steps, and allowed me to tell a story in 
the research. It also helped me to not over complicate the models, which I hope made 
it easier to read.
Overcoming Hurdles
Many hurdles presented themselves during the course of conducting this study. One 
such obstacle concerned gaining ethical clearance for the research. Previous ethical 
and research and development approval had been gained for previous research 
involving the same data set. This meant that only extensions of approval for each 
were required for my study, as amendments to the original study, rather than having 
to complete the NHS ethics form. I assumed that obtaining this amendment would 
not be stressful or time consuming as it had to be passed only by the amendment 
subcommittee. However, this process was slow and it took months to learn that 
ethical consent and research and development clearance had been granted. Thinking 
back over the research process, this meant that the momentum of the project 
development was interrupted, and it was very difficult to persevere with the study at 
that time without the certainty of having ethical approval. The reassurance and 
continuous support that I received from my research supervisor at that time, and 
throughout the research, was very helpful.
Another hurdle to overcome was how to gain my knowledge of SEM and AMOS. At 
the start of the project my knowledge and experience of using SEM techniques and of 
using AMOS was zero. I wanted to attend a training course run by AMOS to teach 
me the basics on top of which I would be able to build independently. I recall being
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disappointed when I was informed that I would not be able to go on the AMOS 
training course as it would cost too much. It felt like my research was being put in 
jeopardy, simply due to financial restraints, and I felt powerless to do anything about 
it. I was therefore forced to set about learning how to use AMOS by reading and by 
doing examples. The AMOS user guide (Arbuckle, 1999) became my bible.
Although completely overwhelming initially, I am struck now by the user-friendliness 
of AMOS. For example, AMOS gave written prompts when running analyses such as 
prompting me that a model was unidentified, or that pairs of latent exogenous 
variables were not correlated. This was helpful when first learning how to use the 
programme. It took much time to learn to use the AMOS graphics package, but 
AMOS’s simple visual representations were helpful for me to get a grasp of the 
difficult statistical concepts and analyses, and made it much easier to explain and 
understand the models to be tested. All the constructs and their interrelationships 
were dearly  displayed which was really helpful to understand what was happening- I 
really liked the way that the multiple regression equations could be represented by a 
diagram, and it took the fear out of performing very sophisticated statistics. Drawing 
figures and having the output displayed on the diagrams also made it easier to 
understand the results and to be able to explain the results to others, who may not 
have had as much knowledge. On reflection, having a good research design made 
using the AMOS statistics package a challenging, yet achievable experience, rather 
than the punishing experience it could well have been.
Retrospectively, I think it would have been difficult for me to make use of the AMOS 
training course opportunities before I had got up to my elbows in analysis. Having to 
leam through reading and doing examples myself meant that my understanding of my
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data and what the package could offer grew quickly. In turn, I noticed that my 
confidence increased, and knowing that I achieved the knowledge independently has 
filled me with a sense of satisfaction and achievement.
Lessons Learnt
Many lessons will be taken away with me from this experience. Two of the most 
important of these lessons, and the ones that will be presented here, are the lesson I 
learnt about my own personal strengths, and a lesson regarding the constraints within 
which all research has to be conducted.
Firstly, on a personal note, I have recognised many of my own strengths and skills 
that I was unaware of prior to this experience. In particular, I have been struck by my 
ability to problem solve, to persevere, and to be flexible when faced with hurdles and 
difficult decisions. In addition, my time management and organisational skills have 
been vital, as it was necessary to prioritise and plan tasks carefully in order to meet 
my deadlines. I also think that my computer skills have flourished, as well as my 
ability to communicate complicated material as simply as possible. Finally, the 
research has shown me that not only am I capable of working independently to meet 
goals, but I have thrived on the satisfaction and the sense of achievement that 
completing such a task independently has given me. I’m sure there were times when 
I wanted to back out early on, and wanted to admit that I could not cope. However, 
looking back it seems that the enormity of my task seemed to motivate me and 
spurred me on to persevere and learn, rather than to throw in the towel. This taught
161
me a lot about my own self diligence and the drive I have to succeed, even when 
faced with difficulties.
Secondly, on reflection, the experience of having to leam how to do structural 
equation modeling independently from books, rather than from a taught course, 
taught me a great deal. It forced me to look for alternative strategies to gain the 
knowledge that I needed. In addition, it taught me the important lesson that all 
research within the NHS has to be conducted under constraints, whether it is time 
constraints and/or financial ones. I learnt how it is necessary to problem solve any 
hurdles that you are faced with, rather than to give in to them.
Finally, completing this research I also learnt hands-on about the sort of compromises 
and decisions that have to be made when using real life clinical data, with missing 
values and discontinuities.
Personal Reflections
Looking back, my journey began on a high. I had secured the amazing opportunity to 
use a large set of archival data in an area of psychology that fascinates me. The 
available literature and research on adherence in persistent pain was very elementary, 
meaning that there was huge scope for me to do some ground breaking research. It 
felt like the world was my oyster in terms of what I wanted to investigate, and what 
statistical methods I would use to do it. However, the reality of what this would 
actually entail soon set in. As I have said, my statistical analyses needed to be ‘very 
sophisticated’, and the logistics of getting my head around such an enormous data set
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and of deciding on and learning how to use complex statistical procedures was very 
frightening. The words ‘structural equation modelling’ and ‘multivariate analysis’ 
filled me with fear, and in the beginning, reading about them only seemed to heighten 
this.
The period of time between my research proposal being submitted and returned was 
filled with anticipation. I recall the relief I felt when the proposal was accepted, 
while also remembering the feeling of fear that I would actually have to do what I 
said I could do. I was sure that my incompetence would be revealed at any point.
When I first came face to face with the data I have to admit that I felt completely 
overwhelmed. It seemed an impossible task to get my head around what was there, to 
familiarise myself with the data, to decide what I wanted to keep, and then to arrange 
this data into a suitable form for my analyses. This process at the time seemed slow, 
and never ending. Data was saved in numerous different files, so the merging of files 
was the first necessary but very time consuming step of turning the data into a single 
workable file. It was helpful to map out clearly what data was available at each time 
point, in order for me to fathom how to begin this immense task. Data were then 
meticulously checked by hand to ensure that all cases with no data were removed and 
to ensure that there were no repeated subject numbers. Looking back, this long 
process was vital to ensure that the data set was clean and as complete as possible for 
analysis. It was also vital for me to familiarise myself with the data set. My 
knowledge of the data and its meaning was strengthened, and I think that completing 
this process made it possible for me to go on and perform the analyses efficiently.
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I recall that as I read the AMOS user guide (Arbuckle, 1999) and a book on structural 
equation modeling (Byrne, 2001) for the first time I waited patiently for that light 
bulb to come on, hoping that at each turn of the page it would suddenly all make 
sense to me. I highlighted everything that seemed important (the whole book was 
highlighted!) and I remember closing the back cover when I had finished the book 
and being filled with dread that the ‘Geronimo’ moment had not come. Looking 
back, there never was a distinct moment when I can say ‘I got it’. Instead, the 
learning curve in developing my knowledge and skills in conducting my analyses 
was slow, steady, and continuous.
I still feel that I have much to learn about this area of statistics, although I can also 
now see how far I have come in terms of my knowledge and confidence. I can now 
quickly and confidently draw, specify and estimate structural models with ease, as 
well as interpret their output. This seemed like an impossible task when the project 
was embarked upon. The words structural equation modeling and multivariate 
statistics no longer fill me with fear, which illustrates for me how far I have come.
Final Comments
I am very pleased with what I have achieved. This research made good use of 
complex statistical methods, using a big sample and based on theory driven 
hypotheses. I feel that I have been able to add a great deal in an area of little 
research. The results have shown important effects, which have clinical implications. 
That said, my only lasting frustration is that I am unable to conclude that my final 
model is definitely right, only that it is the most well fitting one tested. My research
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does not in anyway prove a causal pathway, and I am forced to concede that many 
equivalent models will exist. However this research has provided an adequate basic 
model on which to build in future research.
Using AMOS graphics has increased my interest in quantitative analysis and it 
opened up the possibility for me to overcome any fears I had of statistics. My 
experience of using AMOS and of completing this research can be summarised as 
hard work, but most of all satisfying and rewarding.
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St Thomas' Hospital Research Ethics Committee
19 September 2006
Dr Amanda C de C Williams
Reader in Clinical Health Psychology
Sub-Department of Clinical Health Psychology
University College London
Dear Dr Williams
Study title:
REC reference: 
Protocol Amendment 
Detail:
Estimating the magnitude of change following, and 
modelling change processes in, cognitive behaviour 
therapy for chronic pain 
04/Q0702/54
Part of the data analysis to be done by Charlotte Curran, 
for her thesis for a doctorate of clinical psychology ‘CBT 
for persistent pain - how well can long-term treatment 
gains be predicted on the basis of adherence to 
treatment? under the supervision of Dr Amanda C de C 
Williams
Amendment date: 05 May 2006
Thank you for your letter of 05 May 2006, notifying the Committee of the above amendment.
The amendment has been considered by Dr AJ Williams, the Co-Chair and by , 
Expert Member.
The Committee does not consider this to be a “substantial amendment” as defined in the 
Standard Operating Procedures for Research Ethics Committees. The amendment does not 
therefore require ethical review by the Committee and may be implemented immediately, 
provided that it does not affect the research governance approval for the research given by 
the R&D Department for the relevant NHS care organisation.
Documents received
The documents received were as follows:
D ocum ent Version Date
Covering email 05 May 2006
A n  ^ H w i c n r w  n n m m i t t o o  t n  ^ m i t h  Fp<; t  I n n r l n n  ^ t r p t p n i r  H p p l t h  A u t h o r i t y
Appendix 2 -  Participant questionnaires
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Please bring the questionnaire with vou on
vour appointment dav.
INPUT Pain Management Programme 
Patient Questionnaire
Name:
Address:
Date o f birth:
In order to make a proper assessm en t of your pain problem we need as  
much information as possible about you and your pain. Som e of this can be gained 
from the interview, but we also find it helpful for you to fill out this questionnaire 
before you come.
The questionnaire is intended to give us som e information about your pain, such as 
when it started and what treatments you may have had, as well as som e details 
I about you and your background.
Your answers to all of these questions will help us to get a general picture of you 
and your pain problem. P lease be assured that your answers are totally confidential.
If you have difficulty with any of the questions just leave them blank - we can 
discuss them during your assessm ent.
GP Name: 
Address:
-------------------------------------------------------------------------------------------------
Postcode: ____________________________________
Telephone: ____________________________________
INPUT 1
St. Thomas Hospital 
Postcode:
Telephone:
Treatment for pain problems
Please indicate if you have had any o f the following treatments by circling your answer:
1. medicines (any type)  no yes
2 . surgery  no yes
3. injections/nerve blocks/epidurals  no yes
4. TENS  no yes
5. acupuncture  no yes
6 . bed rest (in hospital)  no yes
7. physiotherapy  no yes
8. traction  no yes
9. hydrotherapy  no yes
10. Alexander technique  no yes
11. saw a psychiatrist  no yes
12. saw a psychologist  no yes
13. relaxation  no yes
14. biofeedback  no yes
15. hypnosis  no yes
16. osteopathy  no yes
17. chiropractic  no yes
18. faith healing  no yes
19. o th e r_________________________________________
Have you had private treatment for the pain? no yes
It will help us to know approximately how much it cost: less than £500
£500 to £1000 
£1000 to £5000 
more than £5000
Do you have private medical insurance? no yes
Do you take medicines for the pain? no yes
If so, do you take them: when needed no yes
regularly by the clock no yes
both no yes
Please list the medicines you currently take for the pain
Drug Dose Times daily
Please list any other drugs you take (not for pain)
1 3 5 1 0 9 8 5 7 9
FOLLOW-UP R E V IE W -  07
Name................     Date
Please fill in the applicable boxes, to let us know how, and how often, you are using what you 
learned on the programme.
STRETCH EXERCISES
How often do you do stretches? How often do you do exercise?
stopped completely □ stopped completely □
less than once a week □ less than once a w eek □
1 - 2 times a week □ 1 - 2  times a week □
3 - 4 times a week □ 3 - 4  times a week □
5 - 6 times a week □ 5 - 6  times a week □
at least once a day □ at least once a day □
How often do you relax?
RELAXATION
When do you use relaxation?
stopped completely □ (You can fill in more than one box.■)
less than once a week □ rests and breaks □
1 - 2  times a week □ increased pain □
3 - 6  times a week □ when stressed □
at least Qnce a day □ during activities □
PACING
How often do you use pacing? ' When do you use pacing?
(You can fill in more than one box.)
□  not at all □
□  when I remember □
□  when the pain is bad □
□  for some activities □
□  indoors only □
□  as a daily approach □
CHALLENGING THOUGHTS
How often do you check your thoughts, and When do you do this?
challenge them if necessary? (You can fill in more than one box)
stopped completely □ not at all □
less than once a week □ when I remember □
1 - 2 times a week □ when the pain is bad □
3 - 6 times a week □ when I'm anxious □
at least once a day □ when I'm depressed □
most of the time □ when someone upsets me □
as a daily approach □
stopped completely 
less than once a week 
1 - 2  times a week 
3 - 6 times a week 
at least once a day 
most of the time
